8-K · 2026-10-21
Alaunos Therapeutics has regained compliance with Nasdaq's stockholders' equity requirement after a recent financing round and merger.
| Name | Alaunos Therapeutics, Inc. |
|---|---|
| CIK | 0001107421 |
| Tickers | TCRT |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | Non-accelerated filer<br>Smaller reporting company |
| SIC | 2834 Pharmaceutical Preparations |
| EIN | 841475642 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | DE DE |
| Phone | (346) 355-4099 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
Alaunos Therapeutics has regained compliance with Nasdaq's stockholders' equity requirement after a recent financing round and merger.
Alaunos Therapeutics announces a new CEO and updates on acquisitions, signaling a strategic shift in the pharmaceutical preparations industry.
1299 filing rows loaded from submissions recent; extra archives: CIK0001107421-submissions-001.json (296 filings, 2001-02-13 to 2010-03-30).
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-16 | 10-Q | 10-Q | 0001193125-26-463638 | 001-33038 | 261561764 | 34 | 7582567 | 1 | 1 | |
| 2026-11-13 | PRE 14A | PRE 14A | 0001193125-26-461060 | 001-33038 | 261554226 | 34 | 3068995 | 1 | 1 | |
| 2026-11-13 | S-3 | S-3 | 0001193125-26-458953 | 333-300017 | 261548663 | 33 | 812332 | 1 | 1 | |
| 2026-10-23 | 8-K | 8-K | 8.01 | 0001193125-26-430507 | 001-33038 | 261482582 | 34 | 177634 | 1 | 1 |
| 2026-10-21 | 8-K | 8-K | 3.01,9.01 | 0001193125-26-427890 | 001-33038 | 261476050 | 34 | 187928 | 1 | 1 |
| 2026-10-15 | SCHEDULE 13D/A | xslSCHEDULE_13D_X02/primary_doc.xml | 0001193805-26-001370 | 005-79364 | 261464108 | 34 | 13660 | |||
| 2026-10-15 | 3 | xslF345X06/ownership.xml | 0001683168-26-007900 | 23438 | ||||||
| 2026-10-15 | SCHEDULE 13D | xslSCHEDULE_13D_X02/primary_doc.xml | 0001683168-26-007898 | 005-79364 | 261463068 | 34 | 51746 | |||
| 2026-10-13 | 8-K | 8-K | 1.01,2.01,3.02,5.02,5.03,7.01,9.01 | 0001193125-26-419829 | 001-33038 | 261455182 | 34 | 16113075 | 1 | 1 |
| 2026-10-09 | 8-K | 8-K | 3.01 | 0001193125-26-419154 | 001-33038 | 261453231 | 34 | 188570 | 1 | 1 |
| 2026-10-08 | 4 | 4 | 0001193125-26-417970 | 4866 | ||||||
| 2026-10-08 | 4 | 4 | 0001193125-26-417971 | 6515 | ||||||
| 2026-10-08 | 4 | 4 | 0001193125-26-417969 | 6451 | ||||||
| 2026-10-08 | 4 | 4 | 0001193125-26-417974 | 4790 | ||||||
| 2026-09-22 | 8-K | 8-K | 1.01,8.01,9.01 | 0001193125-26-397996 | 001-33038 | 261397195 | 34 | 1289539 | 1 | 1 |
| 2026-09-21 | 424B3 | 424B3 | 0001193125-26-396777 | 333-289748 | 261394545 | 33 | 1301825 | |||
| 2026-09-17 | 8-K | 8-K | 3.03,5.03 | 0001193125-26-393462 | 001-33038 | 261385061 | 34 | 347365 | 1 | 1 |
| 2026-08-14 | 10-Q | 10-Q | 0001193125-26-352421 | 001-33038 | 261282627 | 34 | 4851430 | 1 | 1 | |
| 2026-08-11 | 4 | 4 | 0001193125-26-344682 | 4863 | ||||||
| 2026-07-27 | 4 | 4 | 0001193125-26-318114 | 4787 | ||||||
| 2026-07-27 | 4 | 4 | 0001193125-26-318105 | 4863 | ||||||
| 2026-07-27 | 4 | 4 | 0001193125-26-318103 | 6448 | ||||||
| 2026-07-27 | 4 | 4 | 0001193125-26-318100 | 6512 | ||||||
| 2026-07-06 | S-8 | S-8 | 0001193125-26-295169 | 333-297265 | 261153939 | 33 | 273473 | 1 | 1 | |
| 2026-07-02 | 4 | 4 | 0001193125-26-295004 | 4921 | ||||||
| 2026-06-29 | 8-K | 8-K | 8.01,9.01 | 0001193125-26-286914 | 001-33038 | 261131465 | 34 | 249316 | 1 | 1 |
| 2026-06-17 | 4 | 4 | 0001193125-26-274305 | 4921 | ||||||
| 2026-05-27 | 4 | 4 | 0001193125-26-241999 | 4920 | ||||||
| 2026-05-26 | 8-K | 8-K | 8.01,9.01 | 0001193125-26-238237 | 001-33038 | 261016928 | 34 | 24745742 | 1 | 1 |
| 2026-05-18 | 8-K | 8-K | 8.01,9.01 | 0001193125-26-227921 | 001-33038 | 26990829 | 34 | 195967 | 1 | 1 |
| 2026-05-15 | 10-Q | 10-Q | 0001193125-26-227272 | 001-33038 | 26989949 | 34 | 4291022 | 1 | 1 | |
| 2026-05-01 | 4 | 4 | 0001193125-26-201557 | 6455 | ||||||
| 2026-05-01 | 4 | 4 | 0001193125-26-201489 | 6483 | ||||||
| 2026-05-01 | 4 | 4 | 0001193125-26-201474 | 4824 | ||||||
| 2026-04-30 | 10-K/A | 10-K/A | 0001193125-26-197838 | 001-33038 | 26927203 | 34 | 1111644 | 1 | 1 | |
| 2026-04-15 | 8-K | 8-K | 3.01 | 0001193125-26-157126 | 001-33038 | 26864533 | 34 | 167563 | 1 | 1 |
| 2026-03-31 | 10-K | 10-K | 0001193125-26-134720 | 001-33038 | 26822614 | 34 | 9353305 | 1 | 1 | |
| 2026-03-05 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0002094682-26-000002 | 005-79364 | 26724895 | 34 | 658863 | |||
| 2026-03-02 | 8-K | 8-K | 8.01,9.01 | 0001193125-26-084084 | 001-33038 | 26703326 | 34 | 232101 | 1 | 1 |
| 2026-02-24 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0002094682-26-000001 | 005-79364 | 26672655 | 34 | 530071 | |||
| 2026-01-15 | 4 | 4 | 0001193125-26-014117 | 4686 | ||||||
| 2026-01-15 | 4 | 4 | 0001193125-26-014116 | 6346 | ||||||
| 2026-01-15 | 4 | 4 | 0001193125-26-014115 | 6318 | ||||||
| 2026-01-08 | 8-K | 8-K | 1.02,3.03,8.01,9.01 | 0001193125-26-007054 | 001-33038 | 26517513 | 34 | 580908 | 1 | 1 |
| 2025-12-23 | 8-K | 8-K | 8.01 | 0001193125-25-331147 | 001-33038 | 251601737 | 34 | 218944 | 1 | 1 |
| 2025-12-11 | 424B8 | 424B8 | 0001193125-25-316216 | 333-291002 | 251565796 | 33 | 340716 | |||
| 2025-12-05 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0002094682-25-000003 | 005-79364 | 251552663 | 34 | 317994 | |||
| 2025-11-26 | 4 | 4 | 0001193125-25-301033 | 6371 | ||||||
| 2025-11-26 | 4 | 4 | 0001193125-25-301026 | 6347 | ||||||
| 2025-11-26 | 4 | 4 | 0001193125-25-301025 | 4687 | ||||||
| 2025-11-14 | 10-Q | 10-Q | 0001193125-25-282988 | 001-33038 | 251486469 | 34 | 5791609 | 1 | 1 | |
| 2025-11-07 | S-3/A | S-3/A | 0001193125-25-272465 | 333-289748 | 251463176 | 33 | 519453 | |||
| 2025-10-31 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0002094682-25-000002 | 005-79364 | 251439872 | 34 | 2899151 | |||
| 2025-10-30 | SCHEDULE 13D | xslSCHEDULE_13D_X01/primary_doc.xml | 0002094682-25-000001 | 005-79364 | 251437475 | 34 | 2346748 | |||
| 2025-10-22 | S-1 | S-1 | 0001193125-25-245483 | 333-291002 | 251408310 | 33 | 632031 | 1 | 1 | |
| 2025-10-16 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001213900-25-099624 | 005-79364 | 251398247 | 34 | 6811 | |||
| 2025-10-02 | S-3/A | S-3/A | 0001193125-25-227248 | 333-289748 | 251366290 | 33 | 494588 | |||
| 2025-10-01 | CORRESP | filename1.htm | 0001193125-25-227249 | 10058 | ||||||
| 2025-09-17 | UPLOAD | filename1.pdf | 0000000000-25-010141 | 333-289748 | 43765 | |||||
| 2025-09-09 | S-3/A | S-3/A | 0001193125-25-198562 | 333-289748 | 251301410 | 33 | 853861 | |||
| 2025-09-08 | CORRESP | filename1.htm | 0001193125-25-198564 | 30336 | ||||||
| 2025-09-05 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0001213900-25-085149 | 005-79364 | 251297530 | 34 | 11420 | |||
| 2025-09-04 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001213900-25-084258 | 005-79364 | 251291850 | 34 | 8485 | |||
| 2025-09-02 | UPLOAD | filename1.pdf | 0000000000-25-009437 | 333-289748 | 44256 | |||||
| 2025-08-21 | S-3 | S-3 | 0001193125-25-184432 | 333-289748 | 251238205 | 33 | 762740 | 1 | 1 | |
| 2025-08-20 | 4 | 4 | 0000950170-25-110531 | 7132 | ||||||
| 2025-08-20 | 4 | 4 | 0000950170-25-110530 | 5380 | ||||||
| 2025-08-20 | 8-K | 8-K | 8.01 | 0000950170-25-110484 | 001-33038 | 251237720 | 34 | 161056 | 1 | 1 |
| 2025-08-14 | 10-Q | 10-Q | 0000950170-25-108887 | 001-33038 | 251219362 | 34 | 5522108 | 1 | 1 | |
| 2025-07-22 | 8-K | 8-K | 5.02 | 0000950170-25-097591 | 001-33038 | 251140774 | 34 | 159363 | 1 | 1 |
| 2025-07-17 | 4 | 4 | 0000950170-25-096674 | 7860 | ||||||
| 2025-07-17 | 3 | 3 | 0000950170-25-096673 | 21308 | ||||||
| 2025-07-17 | 8-K | 8-K | 5.02,9.01 | 0000950170-25-096656 | 001-33038 | 251131481 | 34 | 169187 | 1 | 1 |
| 2025-07-10 | 8-K | 8-K | 3.03,5.07,9.01 | 0000950170-25-095029 | 001-33038 | 251116611 | 34 | 272959 | 1 | 1 |
| 2025-07-07 | 4 | 4 | 0000950170-25-094387 | 8840 | ||||||
| 2025-07-07 | 4 | 4 | 0000950170-25-094386 | 8891 | ||||||
| 2025-07-07 | 4 | 4 | 0000950170-25-094383 | 5790 | ||||||
| 2025-07-02 | 8-K | 8-K | 3.01,5.02 | 0000950170-25-093263 | 001-33038 | 251102737 | 34 | 177710 | 1 | 1 |
| 2025-07-01 | SCHEDULE 13D | xslSCHEDULE_13D_X01/primary_doc.xml | 0000921895-25-001912 | 005-79364 | 251097994 | 34 | 23094 | |||
| 2025-06-26 | 4 | 4 | 0000950170-25-090589 | 5389 | ||||||
| 2025-06-26 | 4 | 4 | 0000950170-25-090587 | 12667 | ||||||
| 2025-06-26 | 8-K | 8-K | 1.01,7.01,9.01 | 0000950170-25-090202 | 001-33038 | 251075206 | 34 | 772201 | 1 | 1 |
| 2025-06-26 | 8-K | 8-K | 1.01,3.02,3.03,5.03,9.01 | 0000950170-25-090201 | 001-33038 | 251075205 | 34 | 512038 | 1 | 1 |
| 2025-06-24 | 424B3 | 424B3 | 0001193125-25-145739 | 333-266841 | 251069344 | 33 | 444331 | |||
| 2025-06-10 | 8-K | 8-K | 1.01,3.02,9.01 | 0000950170-25-083913 | 001-33038 | 251035291 | 34 | 210513 | 1 | 1 |
| 2025-05-23 | 8-K | 8-K | 1.01,3.02,9.01 | 0000950170-25-077064 | 001-33038 | 25983230 | 34 | 1122715 | 1 | 1 |
| 2025-05-21 | ARS | ARS | 0001193125-25-123682 | 001-33038 | 25970998 | 34 | 1397411 | |||
| 2025-05-21 | DEFA14A | DEFA14A | 0001193125-25-123680 | 001-33038 | 25970994 | 34 | 1083347 | |||
| 2025-05-21 | DEF 14A | DEF 14A | 0001193125-25-123677 | 001-33038 | 25970987 | 34 | 2171338 | 1 | 1 | |
| 2025-05-15 | 10-Q | 10-Q | 0000950170-25-072709 | 001-33038 | 25953925 | 34 | 3971674 | 1 | 1 | |
| 2025-05-14 | SCHEDULE 13D | xslSCHEDULE_13D_X01/primary_doc.xml | 0001213900-25-043211 | 005-79364 | 25944714 | 34 | 15784 | |||
| 2025-05-09 | PRE 14A | PRE 14A | 0001193125-25-116509 | 001-33038 | 25928598 | 34 | 2185441 | 1 | 1 | |
| 2025-04-30 | 10-K/A | 10-K/A | 0000950170-25-061207 | 001-33038 | 25896578 | 34 | 1176164 | 1 | 1 | |
| 2025-04-18 | 8-K | 8-K | 5.02 | 0000950170-25-055903 | 001-33038 | 25850758 | 34 | 169453 | 1 | 1 |
| 2025-04-15 | 4 | 4 | 0000950170-25-054436 | 8961 | ||||||
| 2025-04-15 | 4 | 4 | 0000950170-25-054432 | 5304 | ||||||
| 2025-04-15 | 4 | 4 | 0000950170-25-054429 | 4897 | ||||||
| 2025-04-15 | 8-K | 8-K | 5.02 | 0000950170-25-054309 | 001-33038 | 25840270 | 34 | 184701 | 1 | 1 |
| 2025-04-14 | 8-K | 8-K | 1.01,1.02,3.02,3.03,5.03,9.01 | 0000950170-25-053523 | 001-33038 | 25834350 | 34 | 684872 | 1 | 1 |
| 2025-04-11 | 8-K | 8-K | 3.01,8.01 | 0000950170-25-053325 | 001-33038 | 25832754 | 34 | 160642 | 1 | 1 |
| 2025-04-01 | 4 | 4 | 0000950170-25-048554 | 5618 | ||||||
| 2025-04-01 | 4 | 4 | 0000950170-25-048492 | 5532 | ||||||
| 2025-04-01 | 4 | 4 | 0000950170-25-048491 | 5548 | ||||||
| 2025-03-31 | 10-K | 10-K | 0000950170-25-047758 | 001-33038 | 25793519 | 34 | 9776575 | 1 | 1 | |
| 2025-02-13 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000950170-25-019905 | 005-79364 | 25620473 | 34 | 145638 | |||
| 2025-01-03 | 4 | 4 | 0000950170-25-001257 | 6202 | ||||||
| 2024-12-31 | 144 | xsl144X01/primary_doc.xml | 0001959173-24-008881 | 001-33038 | 241593708 | 33 | 13713 | |||
| 2024-11-14 | SC 13G/A | SC 13G/A | 0001193125-24-258550 | 005-79364 | 241461989 | 34 | 91699 | |||
| 2024-11-14 | 10-Q | 10-Q | 0000950170-24-126793 | 001-33038 | 241457791 | 34 | 4231878 | 1 | 1 | |
| 2024-10-10 | 8-K | 8-K | 1.02,2.02,9.01 | 0000950170-24-113960 | 001-33038 | 241363873 | 34 | 186646 | 1 | 1 |
| 2024-08-16 | 4 | 4 | 0000950170-24-098103 | 5576 | ||||||
| 2024-08-16 | 4 | 4 | 0000950170-24-098045 | 5548 | ||||||
| 2024-08-14 | 10-Q | 10-Q | 0000950170-24-097142 | 001-33038 | 241209141 | 34 | 4634976 | 1 | 1 | |
| 2024-07-17 | 8-K/A | 8-K/A | 3.03,5.03,9.01 | 0000950170-24-084024 | 001-33038 | 241120682 | 34 | 234436 | 1 | 1 |
| 2024-07-17 | 8-K/A | 8-K/A | 8.01,9.01 | 0000950170-24-084023 | 001-33038 | 241120681 | 34 | 228769 | 1 | 1 |
| 2024-07-16 | 8-K | 8-K | 5.03 | 0000950170-24-083765 | 001-33038 | 241118645 | 34 | 217390 | 1 | 1 |
| 2024-07-16 | 8-K | 8-K | 8.01 | 0000950170-24-083764 | 001-33038 | 241118641 | 34 | 213014 | 1 | 1 |
| 2024-06-21 | 8-K | 8-K | 4.01,9.01 | 0000950170-24-076333 | 001-33038 | 241061263 | 34 | 214293 | 1 | 1 |
| 2024-06-12 | 8-K | 8-K | 3.03,5.03,5.07,9.01 | 0000950170-24-072534 | 001-33038 | 241039118 | 34 | 269088 | 1 | 1 |
| 2024-06-10 | 4 | 4 | 0000950170-24-071401 | 7605 | ||||||
| 2024-06-10 | 4 | 4 | 0000950170-24-071400 | 5576 | ||||||
| 2024-06-10 | 4 | 4 | 0000950170-24-071399 | 5449 | ||||||
| 2024-06-10 | 4 | 4 | 0000950170-24-071396 | 5495 | ||||||
| 2024-05-15 | 10-Q | 10-Q | 0000950170-24-060075 | 001-33038 | 24947421 | 34 | 5210656 | 1 | 1 | |
| 2024-04-26 | ARS | ARS | 0001193125-24-118282 | 001-33038 | 24884799 | 34 | 2249594 | |||
| 2024-04-26 | DEFA14A | DEFA14A | 0001193125-24-118265 | 001-33038 | 24884741 | 34 | 351876 | |||
| 2024-04-26 | DEF 14A | DEF 14A | 0001193125-24-118247 | 001-33038 | 24884655 | 34 | 1074361 | |||
| 2024-04-15 | PRE 14A | PRE 14A | 0001193125-24-096391 | 001-33038 | 24845521 | 34 | 1074349 | |||
| 2024-04-01 | 10-K | 10-K | 0000950170-24-038868 | 001-33038 | 24805539 | 34 | 10458053 | 1 | 1 | |
| 2024-02-28 | 3 | 3 | 0000950170-24-022569 | 20403 | ||||||
| 2024-02-22 | 8-K | 8-K | 5.02 | 0001193125-24-042903 | 001-33038 | 24665621 | 34 | 148611 | 1 | 1 |
| 2024-02-20 | 8-K | e619290_8k-at.htm | 8.01,9.01 | 0001193805-24-000251 | 001-33038 | 24653217 | 34 | 194594 | 1 | 1 |
| 2024-02-14 | SC 13G/A | d10943920_13g-a.htm | 0000919574-24-001345 | 005-79364 | 24635115 | 34 | 106443 | |||
| 2024-02-13 | SC 13G/A | SC 13G/A | 0001193125-24-033902 | 005-79364 | 24627299 | 34 | 94452 | |||
| 2024-02-01 | 8-K | e619211_8k-at.htm | 5.03,9.01 | 0001193805-24-000111 | 001-33038 | 24584374 | 34 | 238850 | 1 | 1 |
| 2024-01-29 | 8-K | e619210_8k-at.htm | 8.01,9.01 | 0001193805-24-000103 | 001-33038 | 24570559 | 34 | 235303 | 1 | 1 |
| 2024-01-23 | 4 | 4 | 0000950170-24-006700 | 5551 | ||||||
| 2024-01-22 | 8-K | 8-K | 5.02 | 0001193125-24-012201 | 001-33038 | 24549200 | 34 | 146456 | 1 | 1 |
| 2024-01-03 | 4 | 4 | 0000950170-24-001195 | 7812 | ||||||
| 2024-01-03 | 3 | 3 | 0000950170-24-001161 | 15378 | ||||||
| 2024-01-02 | 8-K | 8-K | 5.02,7.01 | 0001193125-24-000240 | 001-33038 | 24500289 | 34 | 154173 | 1 | 1 |
| 2023-12-28 | 8-K | 8-K | 5.02 | 0001193125-23-305187 | 001-33038 | 231523034 | 34 | 145592 | 1 | 1 |
| 2023-12-22 | 8-K | 8-K | 5.02 | 0001193125-23-301802 | 001-33038 | 231507187 | 34 | 141721 | 1 | 1 |
| 2023-11-15 | 8-K | 8-K | 5.02 | 0001193125-23-277541 | 001-33038 | 231409038 | 34 | 180093 | 1 | 1 |
| 2023-11-14 | 8-K | 8-K | 2.02,3.01,9.01 | 0001193125-23-276662 | 001-33038 | 231401610 | 34 | 218339 | 1 | 1 |
| 2023-11-14 | 10-Q | 10-Q | 0000950170-23-063354 | 001-33038 | 231401599 | 34 | 7322025 | 1 | 1 | |
| 2023-09-28 | 8-K | 8-K | 5.02 | 0001193125-23-245602 | 001-33038 | 231289414 | 34 | 138548 | 1 | 1 |
| 2023-09-05 | 4 | 4 | 0000950170-23-046504 | 5564 | ||||||
| 2023-09-01 | 144 | xsl144X01/primary_doc.xml | 0001974078-23-000135 | 001-33038 | 231231551 | 33 | 4499 | |||
| 2023-08-14 | 10-Q | 10-Q | 0000950170-23-042486 | 001-33038 | 231171236 | 34 | 7297796 | 1 | 1 | |
| 2023-08-14 | 8-K | 8-K | 2.02,9.01 | 0001193125-23-212358 | 001-33038 | 231170447 | 34 | 187226 | 1 | 1 |
| 2023-07-05 | 8-K | 8-K | 3.01 | 0001193125-23-181966 | 001-33038 | 231069114 | 34 | 140966 | 1 | 1 |
| 2023-06-12 | 8-K | 8-K | 3.03,5.03,5.07,9.01 | 0001193125-23-165305 | 001-33038 | 231008260 | 34 | 184532 | 1 | 1 |
| 2023-06-08 | 4 | FORM 4 SUBMISSION | 0000899243-23-014923 | 5543 | ||||||
| 2023-06-08 | 4 | FORM 4 SUBMISSION | 0000899243-23-014920 | 5589 | ||||||
| 2023-06-08 | 4 | FORM 4 SUBMISSION | 0000899243-23-014918 | 5569 | ||||||
| 2023-06-08 | 4 | FORM 4 SUBMISSION | 0000899243-23-014916 | 5568 | ||||||
| 2023-06-08 | 4 | FORM 4 SUBMISSION | 0000899243-23-014913 | 5670 | ||||||
| 2023-06-08 | 4 | FORM 4 SUBMISSION | 0000899243-23-014910 | 5590 | ||||||
| 2023-05-10 | 10-Q | 10-Q | 0000950170-23-020088 | 001-33038 | 23904348 | 34 | 7043217 | 1 | 1 | |
| 2023-05-10 | 8-K | 8-K | 2.02,9.01 | 0001193125-23-140010 | 001-33038 | 23904305 | 34 | 197287 | 1 | 1 |
| 2023-04-25 | DEFA14A | DEFA14A | 0001193125-23-115504 | 001-33038 | 23845747 | 34 | 1101289 | |||
| 2023-04-25 | DEF 14A | DEF 14A | 0001193125-23-115492 | 001-33038 | 23845699 | 34 | 2328177 | |||
| 2023-04-19 | 4 | FORM 4 SUBMISSION | 0000899243-23-011453 | 7948 | ||||||
| 2023-04-19 | 3 | FORM 3 SUBMISSION | 0000899243-23-011452 | 8904 | ||||||
| 2023-04-14 | PRE 14A | PRE 14A | 0001193125-23-102248 | 001-33038 | 23821947 | 34 | 2317796 | |||
| 2023-04-04 | 8-K | 8-K | 1.01 | 0001193125-23-091011 | 001-33038 | 23799232 | 34 | 146436 | 1 | 1 |
| 2023-04-03 | 8-K | 8-K | 1.01 | 0001193125-23-088948 | 001-33038 | 23790681 | 34 | 141786 | 1 | 1 |
| 2023-03-30 | 8-K | 8-K | 5.02,9.01 | 0001193125-23-084520 | 001-33038 | 23777169 | 34 | 177439 | 1 | 1 |
| 2023-03-17 | 4 | FORM 4 SUBMISSION | 0000899243-23-009002 | 5662 | ||||||
| 2023-03-17 | 4 | FORM 4 SUBMISSION | 0000899243-23-009001 | 5635 | ||||||
| 2023-03-17 | 4 | FORM 4 SUBMISSION | 0000899243-23-009000 | 5646 | ||||||
| 2023-03-17 | 4 | FORM 4 SUBMISSION | 0000899243-23-008999 | 5645 | ||||||
| 2023-03-17 | 4 | FORM 4 SUBMISSION | 0000899243-23-008998 | 5633 | ||||||
| 2023-03-07 | 10-K | 10-K | 0000950170-23-006377 | 001-33038 | 23711040 | 34 | 12747700 | 1 | 1 | |
| 2023-03-07 | 8-K | 8-K | 2.02,9.01 | 0001193125-23-062072 | 001-33038 | 23711015 | 34 | 205671 | 1 | 1 |
| 2023-02-14 | SC 13G/A | SC 13G/A | 0001193125-23-038503 | 005-79364 | 23626458 | 34 | 78003 | |||
| 2023-02-14 | SC 13G/A | d9926632_13g-a.htm | 0000919574-23-001518 | 005-79364 | 23626286 | 34 | 109294 | |||
| 2023-02-09 | SC 13G/A | SCHEDULE 13G/A | 0001104659-23-015233 | 005-79364 | 23602183 | 34 | 13105 | |||
| 2023-01-20 | SC 13G/A | Alaunos_Therapeutics_Inc.txt | 0000093751-23-000019 | 005-79364 | 23539021 | 34 | 8405 | |||
| 2023-01-09 | 8-K | FORM 8-K | 7.01,8.01,9.01 | 0001193125-23-004224 | 001-33038 | 23516768 | 34 | 6027883 | 1 | 1 |
| 2023-01-04 | 8-K | 8-K | 3.01 | 0001193125-23-001563 | 001-33038 | 23507406 | 34 | 142620 | 1 | 1 |
| 2022-12-01 | 4 | FORM 4 SUBMISSION | 0000899243-22-037275 | 6812 | ||||||
| 2022-12-01 | 4 | FORM 4 SUBMISSION | 0000899243-22-037274 | 14257 | ||||||
| 2022-11-30 | 8-K | 8-K | 1.01,8.01,9.01 | 0001193125-22-295491 | 001-33038 | 221436257 | 34 | 449616 | 1 | 1 |
| 2022-11-30 | 424B5 | FORM 424(B)(5) | 0001193125-22-295486 | 333-266841 | 221436246 | 33 | 651821 | |||
| 2022-11-28 | 424B5 | FORM 424(B)(5) | 0001193125-22-293389 | 333-266841 | 221425418 | 33 | 655592 | |||
| 2022-11-14 | 10-Q | 10-Q | 0000950170-22-024695 | 001-33038 | 221380279 | 34 | 10528149 | 1 | 1 | |
| 2022-11-14 | 8-K | 8-K | 2.02,7.01,9.01 | 0001193125-22-283649 | 001-33038 | 221380113 | 34 | 7468375 | 1 | 1 |
| 2022-11-07 | 8-K | 8-K | 7.01,9.01 | 0001193125-22-278556 | 001-33038 | 221363801 | 34 | 164498 | 1 | 1 |
| 2022-09-30 | 8-K | 8-K | 8.01,9.01 | 0001193125-22-254857 | 001-33038 | 221282327 | 34 | 7504062 | 1 | 1 |
| 2022-09-21 | 8-K | 8-K | 7.01,9.01 | 0001193125-22-248092 | 001-33038 | 221255074 | 34 | 170030 | 1 | 1 |
| 2022-09-19 | 4 | FORM 4 SUBMISSION | 0000899243-22-031464 | 11395 | ||||||
| 2022-09-19 | 4 | FORM 4 SUBMISSION | 0000899243-22-031462 | 5654 | ||||||
| 2022-09-19 | 4 | FORM 4 SUBMISSION | 0000899243-22-031460 | 11224 | ||||||
| 2022-09-19 | 4 | FORM 4 SUBMISSION | 0000899243-22-031459 | 5601 | ||||||
| 2022-09-07 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2022-09-07 16:00:00 | 9999999995-22-002609 | 333-266841 | 221232428 | 33 | 1856 | ||
| 2022-09-07 | 424B5 | 424B5 | 0001193125-22-240009 | 333-266841 | 221231369 | 33 | 444418 | |||
| 2022-09-06 | 8-K | 8-K | 8.01,9.01 | 0001193125-22-238444 | 001-33038 | 221226955 | 34 | 162692 | 1 | 1 |
| 2022-09-02 | CORRESP | filename1.htm | 0001193125-22-237887 | 5889 | ||||||
| 2022-09-01 | 4 | FORM 4 SUBMISSION | 0000899243-22-030186 | 4991 | ||||||
| 2022-08-31 | S-3/A | S-3/A | 0001193125-22-235248 | 333-266841 | 221218437 | 33 | 763513 | |||
| 2022-08-24 | 8-K | 8-K | 7.01,9.01 | 0001193125-22-228590 | 001-33038 | 221192039 | 34 | 158585 | 1 | 1 |
| 2022-08-19 | UPLOAD | filename1.pdf | 0000000000-22-008920 | 40300 | ||||||
| 2022-08-16 | 4 | FORM 4 SUBMISSION | 0000899243-22-028813 | 5680 | ||||||
| 2022-08-15 | 3 | FORM 3 SUBMISSION | 0000899243-22-028659 | 9797 | ||||||
| 2022-08-15 | 10-Q | 10-Q | 0000950170-22-017225 | 001-33038 | 221162340 | 34 | 7925243 | 1 | 1 | |
| 2022-08-15 | 8-K | 8-K | 2.02,9.01 | 0001193125-22-220540 | 001-33038 | 221162283 | 34 | 185004 | 1 | 1 |
| 2022-08-12 | S-3 | S-3 | 0001193125-22-220066 | 333-266841 | 221161066 | 33 | 1647952 | |||
| 2022-08-04 | 8-K | 8-K | 7.01,9.01 | 0001193125-22-212664 | 001-33038 | 221137716 | 34 | 159367 | 1 | 1 |
| 2022-07-13 | 8-K | 8-K | 8.01 | 0001193125-22-192331 | 001-33038 | 221080218 | 34 | 139961 | 1 | 1 |
| 2022-07-08 | SC 13G | us98973p1012_070822.txt | 0000834237-22-010175 | 005-79364 | 221074971 | 34 | 12303 | |||
| 2022-06-27 | 8-K | 8-K | 1.01,7.01,9.01 | 0001193125-22-182171 | 001-33038 | 221041618 | 34 | 166969 | 1 | 1 |
| 2022-06-24 | 4 | FORM 4 SUBMISSION | 0000899243-22-024011 | 6938 | ||||||
| 2022-06-24 | 4 | FORM 4 SUBMISSION | 0000899243-22-024006 | 12703 | ||||||
| 2022-06-24 | 4 | FORM 4 SUBMISSION | 0000899243-22-024005 | 14690 | ||||||
| 2022-06-24 | 4 | FORM 4 SUBMISSION | 0000899243-22-023997 | 6938 | ||||||
| 2022-06-24 | 4 | FORM 4 SUBMISSION | 0000899243-22-023988 | 12703 | ||||||
| 2022-06-24 | 4 | FORM 4 SUBMISSION | 0000899243-22-023987 | 14690 | ||||||
| 2022-06-24 | 4 | FORM 4 SUBMISSION | 0000899243-22-023985 | 9817 | ||||||
| 2022-06-24 | 4 | FORM 4 SUBMISSION | 0000899243-22-023978 | 6936 | ||||||
| 2022-06-24 | 4 | FORM 4 SUBMISSION | 0000899243-22-023977 | 15627 | ||||||
| 2022-06-17 | 8-K | 8-K | 3.03,5.03,5.07,9.01 | 0001193125-22-176544 | 001-33038 | 221024338 | 34 | 179745 | 1 | 1 |
| 2022-05-24 | 8-K | 8-K | 7.01,9.01 | 0001193125-22-158062 | 001-33038 | 22954076 | 34 | 4907123 | 1 | 1 |
| 2022-05-16 | 10-Q | 10-Q | 0000950170-22-009942 | 001-33038 | 22925468 | 34 | 6051674 | 1 | 1 | |
| 2022-05-16 | 8-K | 8-K | 2.02,9.01 | 0001193125-22-150889 | 001-33038 | 22925463 | 34 | 182666 | 1 | 1 |
| 2022-05-02 | 8-K | 8-K | 7.01,9.01 | 0001193125-22-136842 | 001-33038 | 22882463 | 34 | 163530 | 1 | 1 |
| 2022-05-02 | 8-K | 8-K | 8.01,9.01 | 0001193125-22-135461 | 001-33038 | 22879540 | 34 | 162602 | 1 | 1 |
| 2022-04-27 | DEFA14A | DEFA14A | 0001193125-22-123724 | 001-33038 | 22860258 | 34 | 553713 | |||
| 2022-04-27 | DEF 14A | DEF 14A | 0001193125-22-123703 | 001-33038 | 22860123 | 34 | 936640 | |||
| 2022-04-15 | PRE 14A | PRE 14A | 0001193125-22-106850 | 001-33038 | 22830334 | 34 | 1410768 | |||
| 2022-04-08 | 3 | FORM 3 SUBMISSION | 0000899243-22-014358 | 10293 | ||||||
| 2022-04-01 | 4 | FORM 4 SUBMISSION | 0000899243-22-013119 | 11232 | ||||||
| 2022-04-01 | 4 | FORM 4 SUBMISSION | 0000899243-22-013117 | 11212 | ||||||
| 2022-03-30 | S-8 | S-8 | 0001193125-22-089868 | 333-263983 | 22786920 | 33 | 88234 | |||
| 2022-03-30 | 10-K | 10-K | 0000950170-22-004972 | 001-33038 | 22783178 | 34 | 14100462 | 1 | 1 | |
| 2022-03-30 | 8-K | 8-K | 2.02,9.01 | 0001193125-22-088653 | 001-33038 | 22783172 | 34 | 195309 | 1 | 1 |
| 2022-03-18 | 8-K | 8-K | 3.01 | 0001193125-22-079589 | 001-33038 | 22753250 | 34 | 143158 | 1 | 1 |
| 2022-03-17 | 8-K | 8-K | 1.01,7.01,9.01 | 0001193125-22-077889 | 001-33038 | 22746868 | 34 | 5193839 | 1 | 1 |
| 2022-02-14 | SC 13G/A | d9181468_13g-a.htm | 0000919574-22-001633 | 005-79364 | 22634450 | 34 | 108137 | |||
| 2022-02-11 | SC 13G | ZIOPHARM_ONCOLOGY_INC.txt | 0000093751-22-000305 | 005-79364 | 22619850 | 34 | 8598 | |||
| 2022-02-11 | SC 13G/A | SCHEDULE 13G | 0001674751-22-000002 | 005-79364 | 22618803 | 34 | 447024 | |||
| 2022-02-10 | SC 13G/A | SCHEDULE 13G/A | 0001104659-22-018959 | 005-79364 | 22611288 | 34 | 13142 | |||
| 2022-02-03 | SC 13G/A | us98973p1012_020222.txt | 0000834237-22-005462 | 005-79364 | 22585713 | 34 | 13547 | |||
| 2022-01-26 | 8-K | 8-K | 5.03,7.01,8.01,9.01 | 0001193125-22-017681 | 001-33038 | 22555692 | 34 | 5167962 | 1 | 1 |
| 2022-01-04 | 8-K | 8-K | 1.01,2.03,3.02 | 0001193125-22-001682 | 001-33038 | 22505805 | 34 | 193858 | 1 | 1 |
| 2021-12-27 | 4 | FORM 4 SUBMISSION | 0000899243-21-049739 | 5460 | ||||||
| 2021-12-13 | 4 | FORM 4 SUBMISSION | 0000899243-21-047850 | 5608 | ||||||
| 2021-12-09 | 3 | FORM 3 SUBMISSION | 0000899243-21-047494 | 3060 | ||||||
| 2021-11-29 | 3 | FORM 3 SUBMISSION | 0001209191-21-067034 | 8552 | ||||||
| 2021-11-17 | 4 | FORM 4 SUBMISSION | 0001209191-21-065138 | 6219 | ||||||
| 2021-11-08 | 10-Q | 10-Q | 0000950170-21-003463 | 001-33038 | 211388024 | 34 | 9150902 | 1 | 1 | |
| 2021-11-05 | 8-K | 8-K | 5.02 | 0000950170-21-003235 | 001-33038 | 211384585 | 34 | 163878 | 1 | 1 |
| 2021-10-12 | SC 13G/A | MILLER VALUE PARTNERS, LLC | 0001085146-21-002718 | 005-79364 | 211318214 | 34 | 47759 | |||
| 2021-10-04 | 4 | FORM 4 SUBMISSION | 0001209191-21-059131 | 8012 | ||||||
| 2021-10-01 | 8-K | 8-K | 5.02 | 0000950170-21-001975 | 001-33038 | 211298915 | 34 | 164363 | 1 | 1 |
| 2021-09-27 | 8-K | 8-K | 2.05,7.01,9.01 | 0000950170-21-001903 | 001-33038 | 211281712 | 34 | 212563 | 1 | 1 |
| 2021-09-03 | 4 | FORM 4 SUBMISSION | 0001209191-21-054829 | 5145 | ||||||
| 2021-09-03 | 4 | FORM 4 SUBMISSION | 0001209191-21-054828 | 7530 | ||||||
| 2021-09-03 | 4 | FORM 4 SUBMISSION | 0001209191-21-054825 | 7542 | ||||||
| 2021-09-03 | 4 | FORM 4 SUBMISSION | 0001209191-21-054824 | 5140 | ||||||
| 2021-08-31 | 4 | FORM 4 SUBMISSION | 0001209191-21-054089 | 7450 | ||||||
| 2021-08-31 | 3 | FORM 3 SUBMISSION | 0001209191-21-054087 | 7326 | ||||||
| 2021-08-30 | 8-K | 8-K | 5.02,9.01 | 0001193125-21-260859 | 001-33038 | 211224601 | 34 | 300026 | 1 | 1 |
| 2021-08-13 | 10-Q | 10-Q | 0000950170-21-001446 | 001-33038 | 211173138 | 34 | 6680869 | 1 | 1 | |
| 2021-08-12 | 8-K | 8-K | 1.01,2.03,3.02 | 0001193125-21-244836 | 001-33038 | 211168435 | 34 | 164772 | 1 | 1 |
| 2021-08-09 | NT 10-Q | NT 10-Q | 0001193125-21-240604 | 001-33038 | 211157369 | 34 | 22483 | |||
| 2021-08-09 | 8-K | 8-K | 2.02,9.01 | 0001193125-21-240592 | 001-33038 | 211157341 | 34 | 190317 | 1 | 1 |
| 2021-05-21 | 8-K | 8-K | 3.03,5.02,5.03,5.07,7.01,9.01 | 0001193125-21-169242 | 001-33038 | 21948925 | 34 | 220584 | 1 | 1 |
| 2021-05-19 | 4 | FORM 4 SUBMISSION | 0001209191-21-034027 | 4943 | ||||||
| 2021-05-13 | 8-K | 8-K | 5.02 | 0001193125-21-160554 | 001-33038 | 21920116 | 34 | 148577 | 1 | 1 |
| 2021-05-06 | 4 | FORM 4 SUBMISSION | 0001209191-21-030746 | 12321 | ||||||
| 2021-05-06 | 4 | FORM 4 SUBMISSION | 0001209191-21-030745 | 12276 | ||||||
| 2021-05-06 | 4 | FORM 4 SUBMISSION | 0001209191-21-030743 | 9400 | ||||||
| 2021-05-06 | 4 | FORM 4 SUBMISSION | 0001209191-21-030742 | 11385 | ||||||
| 2021-05-06 | 4 | FORM 4 SUBMISSION | 0001209191-21-030740 | 7064 | ||||||
| 2021-05-06 | 4 | FORM 4 SUBMISSION | 0001209191-21-030738 | 7031 | ||||||
| 2021-05-06 | 4 | FORM 4 SUBMISSION | 0001209191-21-030737 | 7045 | ||||||
| 2021-05-06 | 10-Q | 10-Q | 0001193125-21-153365 | 001-33038 | 21898450 | 34 | 4668032 | 1 | 1 | |
| 2021-05-06 | 8-K | 8-K | 2.02,2.05,9.01 | 0001193125-21-153304 | 001-33038 | 21898028 | 34 | 207019 | 1 | 1 |
| 2021-04-09 | 8-K | 8-K | 5.02,9.01 | 0001193125-21-111091 | 001-33038 | 21816616 | 34 | 418529 | 1 | 1 |
| 2021-04-07 | DEFA14A | DEFA14A | 0001193125-21-108287 | 001-33038 | 21810830 | 34 | 936509 | |||
| 2021-04-07 | DEF 14A | DEF 14A | 0001193125-21-108283 | 001-33038 | 21810822 | 34 | 2286272 | |||
| 2021-03-31 | 3 | FORM 3 SUBMISSION | 0001209191-21-023775 | 9426 | ||||||
| 2021-03-25 | PRE 14A | PRE 14A | 0001193125-21-094507 | 001-33038 | 21772823 | 34 | 2280982 | |||
| 2021-03-25 | 8-K | 8-K | 5.02 | 0001193125-21-094494 | 001-33038 | 21772773 | 34 | 148949 | 1 | 1 |
| 2021-03-22 | 3 | FORM 3 SUBMISSION | 0001209191-21-022396 | 10717 | ||||||
| 2021-03-22 | 3 | FORM 3 SUBMISSION | 0001209191-21-022395 | 10669 | ||||||
| 2021-03-22 | 3 | FORM 3 SUBMISSION | 0001209191-21-022394 | 11197 | ||||||
| 2021-03-11 | SEC STAFF LETTER | filename1.pdf | 9999999997-21-000656 | 276082 | ||||||
| 2021-03-08 | 4 | FORM 4 SUBMISSION | 0001209191-21-018632 | 7248 | ||||||
| 2021-03-08 | 4 | FORM 4 SUBMISSION | 0001209191-21-018630 | 7248 | ||||||
| 2021-03-08 | 4 | FORM 4 SUBMISSION | 0001209191-21-018629 | 7174 | ||||||
| 2021-03-08 | 4 | FORM 4 SUBMISSION | 0001209191-21-018628 | 7290 | ||||||
| 2021-03-02 | 8-K | 8-K | 5.02,9.01 | 0001193125-21-065465 | 001-33038 | 21703431 | 34 | 267301 | 1 | 1 |
| 2021-03-01 | 10-K | 10-K | 0001193125-21-063387 | 001-33038 | 21697628 | 34 | 12668323 | 1 | 1 | |
| 2021-02-26 | 3 | FORM 3 SUBMISSION | 0001209191-21-014839 | 7284 | ||||||
| 2021-02-25 | 8-K | 8-K | 2.02,9.01 | 0001193125-21-056943 | 001-33038 | 21680259 | 34 | 218598 | 1 | 1 |
| 2021-02-23 | 8-K | 8-K | 5.02,9.01 | 0001193125-21-052339 | 001-33038 | 21665442 | 34 | 215699 | 1 | 1 |
| 2021-02-16 | SC 13G/A | SCHEDULE 13G | 0001804350-21-000001 | 005-79364 | 21635373 | 34 | 17761 | |||
| 2021-02-16 | SC 13G/A | MILLER VALUE PARTNERS, LLC | 0001085146-21-000853 | 005-79364 | 21633793 | 34 | 49280 | |||
| 2021-02-10 | SC 13G/A | SCHEDULE 13G/A | 0001104659-21-019475 | 005-79364 | 21612403 | 34 | 13998 | |||
| 2021-02-10 | SEC STAFF LETTER | filename1.pdf | 9999999997-21-000619 | 277145 | ||||||
| 2021-02-05 | 8-K | 8-K | 1.01,5.02,8.01,9.01 | 0001193125-21-030026 | 001-33038 | 21594024 | 34 | 275642 | 1 | 1 |
| 2021-02-01 | SC 13G/A | us98973p1012_013121.txt | 0000834237-21-005571 | 005-79364 | 21574584 | 34 | 13542 | |||
| 2021-01-14 | 8-K | 8-K | 7.01,9.01 | 0001193125-21-008651 | 001-33038 | 21527538 | 34 | 9965772 | 1 | 1 |
| 2021-01-12 | 4 | FORM 4 SUBMISSION | 0001209191-21-003245 | 5481 | ||||||
| 2021-01-12 | 4 | FORM 4 SUBMISSION | 0001209191-21-003244 | 4966 | ||||||
| 2021-01-12 | 4 | FORM 4 SUBMISSION | 0001209191-21-003242 | 5481 | ||||||
| 2021-01-07 | SC 13G | d8718385_13-g.htm | 0000919574-21-000073 | 005-79364 | 21514436 | 34 | 124924 | |||
| 2021-01-06 | 4 | FORM 4 SUBMISSION | 0001209191-21-002174 | 5489 | ||||||
| 2021-01-06 | 4 | FORM 4 SUBMISSION | 0001209191-21-002171 | 5514 | ||||||
| 2020-12-30 | 8-K | 8-K | 3.01 | 0001193125-20-329908 | 001-33038 | 201426492 | 34 | 151662 | 1 | 1 |
| 2020-12-18 | 8-K | CURRENT REPORT | 3.01,5.02,5.03,5.07,8.01,9.01 | 0001213900-20-043385 | 001-33038 | 201398071 | 34 | 307582 | 1 | 1 |
| 2020-12-17 | DFAN14A | dfan14a12766002_12172020.htm | 0000921895-20-003264 | 001-33038 | 201396767 | 34 | 190032 | |||
| 2020-12-17 | DEFA14A | DEFA14A | 0001213900-20-043100 | 001-33038 | 201393454 | 34 | 29843 | |||
| 2020-12-15 | 8-K | 8-K | 5.02,9.01 | 0001193125-20-318183 | 001-33038 | 201390217 | 34 | 168312 | 1 | 1 |
| 2020-12-14 | DFAN14A | dfan14a12766002_12142020.htm | 0000921895-20-003232 | 001-33038 | 201386228 | 34 | 104320 | |||
| 2020-12-14 | DEFA14A | DEFINITIVE ADDITIONAL MATERIALS | 0001213900-20-042404 | 001-33038 | 201385143 | 34 | 44258 | |||
| 2020-12-11 | DEFA14A | DEFINITIVE ADDITIONAL MATERIALS | 0001213900-20-042162 | 001-33038 | 201382526 | 34 | 62160 | |||
| 2020-12-08 | DFAN14A | dfan14a12766002_12072020.htm | 0000921895-20-003189 | 001-33038 | 201375996 | 34 | 142388 | |||
| 2020-12-08 | 8-K | 8-K | 5.02 | 0001193125-20-312748 | 001-33038 | 201375480 | 34 | 149024 | 1 | 1 |
| 2020-12-04 | DEFA14A | DEFINITIVE ADDITIONAL MATERIALS | 0001213900-20-041145 | 001-33038 | 201370739 | 34 | 77303 | |||
| 2020-12-04 | DEFA14A | DEFINITIVE ADDITIONAL MATERIALS | 0001213900-20-041143 | 001-33038 | 201370735 | 34 | 3040058 | |||
| 2020-12-03 | DFAN14A | dfan14a12766002_12032020.htm | 0000921895-20-003169 | 001-33038 | 201366810 | 34 | 128761 | |||
| 2020-12-02 | DFAN14A | dfan14a12766002_12022020.htm | 0000921895-20-003159 | 001-33038 | 201363748 | 34 | 1548520 | |||
| 2020-11-30 | DEFA14A | DEFINITIVE ADDITIONAL MATERIALS | 0001213900-20-040038 | 001-33038 | 201359122 | 34 | 22892354 | |||
| 2020-11-30 | DFAN14A | dfan14a12766002_11302020.htm | 0000921895-20-003134 | 001-33038 | 201358781 | 34 | 127682 | |||
| 2020-11-27 | DEFA14A | FORM DEFA14A | 0001213900-20-039716 | 001-33038 | 201355954 | 34 | 42947 | |||
| 2020-11-27 | DEFA14A | DEFINITIVE ADDITIONAL MATERIALS | 0001213900-20-039714 | 001-33038 | 201355940 | 34 | 83194 | |||
| 2020-11-27 | DFAN14A | e620106_dfan14a-ziopharm.htm | 0000921895-20-003122 | 001-33038 | 201354921 | 34 | 106079 | |||
| 2020-11-24 | DFAN14A | dfan14a12766002_11242020.htm | 0000921895-20-003103 | 001-33038 | 201344587 | 34 | 137891 | |||
| 2020-11-23 | DFAN14A | dfan14a12766002_11232020.htm | 0000921895-20-003097 | 001-33038 | 201339040 | 34 | 3615797 | |||
| 2020-11-20 | DEFA14A | DEFINITIVE ADDITIONAL MATERIALS | 0001213900-20-038408 | 001-33038 | 201331222 | 34 | 42025 | |||
| 2020-11-20 | DEFA14A | DEFINITIVE ADDITIONAL MATERIALS | 0001213900-20-038287 | 001-33038 | 201329759 | 34 | 7127241 | |||
| 2020-11-19 | 3 | FORM 3 SUBMISSION | 0001209191-20-059429 | 7203 | ||||||
| 2020-11-19 | DEFA14A | DEFINITIVE ADDITIONAL MATERIALS | 0001213900-20-038254 | 001-33038 | 201329349 | 34 | 521430 | |||
| 2020-11-19 | 8-K | CURRENT REPORT | 5.02,9.01 | 0001213900-20-038252 | 001-33038 | 201329334 | 34 | 264743 | 1 | 1 |
| 2020-11-19 | DFAN14A | dfan14a12766002_11192020.htm | 0000921895-20-003052 | 001-33038 | 201328968 | 34 | 2718013 | |||
| 2020-11-18 | SC 13G/A | SC 13G/A | 0001104659-20-126942 | 005-79364 | 201326099 | 34 | 187758 | |||
| 2020-11-18 | DFAN14A | dfan14a12766002_11182020.htm | 0000921895-20-003037 | 001-33038 | 201325991 | 34 | 2655588 | |||
| 2020-11-16 | DFAN14A | dfan14a12766002_11162020.htm | 0000921895-20-003000 | 001-33038 | 201315784 | 34 | 125669 | |||
| 2020-11-13 | DFAN14A | dfan14a12766002_11132020.htm | 0000921895-20-002944 | 001-33038 | 201312314 | 34 | 121009 | |||
| 2020-11-12 | DFAN14A | dfan14a12766002_11122020.htm | 0000921895-20-002893 | 001-33038 | 201306163 | 34 | 159566 | |||
| 2020-11-05 | DFAN14A | dfan14a12766002_11052020.htm | 0000921895-20-002806 | 001-33038 | 201291573 | 34 | 1024561 | |||
| 2020-11-05 | 8-K | 8-K | 2.02,7.01,9.01 | 0001193125-20-286826 | 001-33038 | 201290469 | 34 | 5103402 | 1 | 1 |
| 2020-11-05 | 10-Q | 10-Q | 0001193125-20-286807 | 001-33038 | 201290342 | 34 | 5174890 | 1 | 1 | |
| 2020-11-04 | DFRN14A | dfrn14a12766002_11042020.htm | 0000921895-20-002790 | 001-33038 | 201286743 | 34 | 101607 | |||
| 2020-11-02 | DEFA14A | FORM DEFA14A | 0001213900-20-034575 | 001-33038 | 201281304 | 34 | 5021436 | |||
| 2020-11-02 | DFAN14A | dfan14a12766002_11022020.htm | 0000921895-20-002762 | 001-33038 | 201280455 | 34 | 42407 | |||
| 2020-11-02 | DEFA14A | DEFINITIVE ADDITIONAL MATERIALS | 0001213900-20-034421 | 001-33038 | 201279161 | 34 | 76044 | |||
| 2020-11-02 | DEFA14A | DEFINITIVE ADDITIONAL MATERIALS | 0001213900-20-034417 | 001-33038 | 201279148 | 34 | 116381 | |||
| 2020-11-02 | DEFC14A | defc1020_ziopharm.htm | 0001213900-20-034356 | 001-33038 | 201279067 | 34 | 5077023 | |||
| 2020-10-30 | DEFC14A | defc14a12766002_10302020.htm | 0000921895-20-002751 | 001-33038 | 201277925 | 34 | 513420 | |||
| 2020-10-29 | PRRN14A | prrn14a12766002_10292020.htm | 0000921895-20-002726 | 001-33038 | 201273249 | 34 | 513939 | |||
| 2020-10-28 | PRRN14A | prrn14a12766002_10282020.htm | 0000921895-20-002713 | 001-33038 | 201269628 | 34 | 511986 | |||
| 2020-10-28 | UPLOAD | filename1.pdf | 0000000000-20-010194 | 243017 | ||||||
| 2020-10-27 | PRER14A | PRELIMINARY REVISED PROXY STATEMENT | 0001213900-20-033544 | 001-33038 | 201264293 | 34 | 1648414 | |||
| 2020-10-27 | CORRESP | filename1.htm | 0001213900-20-033522 | 33296 | ||||||
| 2020-10-27 | UPLOAD | filename1.pdf | 0000000000-20-010137 | 234924 | ||||||
| 2020-10-26 | PRRN14A | prrn14a12766002_10262020.htm | 0000921895-20-002699 | 001-33038 | 201261533 | 34 | 469967 | |||
| 2020-10-22 | UPLOAD | filename1.pdf | 0000000000-20-010022 | 267459 | ||||||
| 2020-10-21 | PREC14A | PRELIMINARY PROXY STATEMENT | 0001213900-20-032558 | 001-33038 | 201251093 | 34 | 812780 | |||
| 2020-10-16 | DEFA14A | DEFA14A | 0001193125-20-271219 | 001-33038 | 201244623 | 34 | 30742 | |||
| 2020-10-16 | PREC14A | prec14a12766002_10142020.htm | 0000921895-20-002619 | 001-33038 | 201243485 | 34 | 466938 | |||
| 2020-10-13 | 4 | FORM 4 SUBMISSION | 0001209191-20-054667 | 5491 | ||||||
| 2020-10-01 | 8-K | 8-K | 1.01 | 0001193125-20-260571 | 001-33038 | 201214528 | 34 | 150888 | 1 | 1 |
| 2020-09-28 | 3 | FORM 3 SUBMISSION | 0001209191-20-052214 | 7157 | ||||||
| 2020-09-22 | 8-K | 8-K | 5.02,5.03,9.01 | 0001193125-20-250711 | 001-33038 | 201187949 | 34 | 268386 | 1 | 1 |
| 2020-08-06 | S-8 | S-8 | 0001193125-20-212035 | 333-241698 | 201082608 | 33 | 74576 | |||
| 2020-08-06 | 8-K | 8-K | 2.02,9.01 | 0001193125-20-211899 | 001-33038 | 201081720 | 34 | 212158 | 1 | 1 |
| 2020-08-06 | 10-Q | 10-Q | 0001193125-20-211865 | 001-33038 | 201081430 | 34 | 4994060 | 1 | 1 | |
| 2020-07-24 | 8-K | 8-K | 5.02 | 0001193125-20-198249 | 001-33038 | 201045270 | 34 | 155381 | 1 | 1 |
| 2020-07-22 | 4 | FORM 4 SUBMISSION | 0001209191-20-043323 | 5352 | ||||||
| 2020-07-22 | 3 | FORM 3 SUBMISSION | 0001209191-20-043319 | 7202 | ||||||
| 2020-07-01 | 8-K | 8-K | 5.02,5.07,9.01 | 0001193125-20-184639 | 001-33038 | 201004005 | 34 | 407000 | 1 | 1 |
| 2020-05-29 | 8-K | 8-K | 5.02,8.01,9.01 | 0001193125-20-155032 | 001-33038 | 20924089 | 34 | 280270 | 1 | 1 |
| 2020-05-18 | DEFA14A | DEFA14A | 0001193125-20-145101 | 001-33038 | 20890233 | 34 | 565214 | |||
| 2020-05-18 | DEF 14A | DEF 14A | 0001193125-20-145086 | 001-33038 | 20890145 | 34 | 1899390 | |||
| 2020-05-08 | PRE 14A | PRE 14A | 0001193125-20-137017 | 001-33038 | 20858812 | 34 | 1898750 | |||
| 2020-05-08 | S-8 | S-8 | 0001193125-20-136509 | 333-238090 | 20858005 | 33 | 148149 | |||
| 2020-05-07 | 8-K | 8-K | 2.02,9.01 | 0001193125-20-136234 | 001-33038 | 20856449 | 34 | 216534 | 1 | 1 |
| 2020-05-07 | 10-Q | 10-Q | 0001193125-20-136200 | 001-33038 | 20856174 | 34 | 4845522 | 1 | 1 | |
| 2020-04-29 | 10-K/A | 10-K/A | 0001193125-20-126370 | 001-33038 | 20831100 | 34 | 570181 | |||
| 2020-03-02 | 8-K | 8-K | 2.02,9.01 | 0001193125-20-058964 | 001-33038 | 20677203 | 34 | 96168 | ||
| 2020-03-02 | 10-K | 10-K | 0001193125-20-058863 | 001-33038 | 20676770 | 34 | 9713106 | 1 | ||
| 2020-02-24 | SC 13G | SCHEDULE 13G | 0001804350-20-000001 | 005-79364 | 20643197 | 34 | 89800 | |||
| 2020-02-14 | SC 13G/A | msdpartnersziopharm13ga.htm | 0001123292-20-000273 | 005-79364 | 20621293 | 34 | 338479 | |||
| 2020-02-14 | SC 13G/A | MILLER VALUE PARTNERS, LLC | 0001085146-20-000816 | 005-79364 | 20618173 | 34 | 49288 | |||
| 2020-02-11 | SC 13G | SCHEDULE 13G | 0001104659-20-016345 | 005-79364 | 20597237 | 34 | 13788 | |||
| 2020-02-06 | 8-K | 8-K | 1.01,8.01 | 0001193125-20-026318 | 001-33038 | 20581449 | 34 | 316873 | ||
| 2020-02-06 | SC 13G/A | us98973p1012_020520.txt | 0000834237-20-006746 | 005-79364 | 20581262 | 34 | 13462 | |||
| 2020-02-05 | 424B5 | 424B5 | 0001193125-20-025491 | 333-232283 | 20579817 | 33 | 811893 | |||
| 2020-02-05 | 8-K | 8-K | 2.02,8.01,9.01 | 0001193125-20-024518 | 001-33038 | 20576219 | 34 | 122046 | ||
| 2020-02-04 | 424B5 | 424B5 | 0001193125-20-024354 | 333-232283 | 20575070 | 33 | 807290 | |||
| 2020-01-31 | 4 | FORM 4 SUBMISSION | 0001209191-20-005789 | 7280 | ||||||
| 2020-01-31 | 4 | FORM 4 SUBMISSION | 0001209191-20-005787 | 7272 | ||||||
| 2020-01-31 | 4 | FORM 4 SUBMISSION | 0001209191-20-005785 | 4841 | ||||||
| 2020-01-31 | 4 | FORM 4 SUBMISSION | 0001209191-20-005783 | 7234 | ||||||
| 2020-01-31 | 4 | FORM 4 SUBMISSION | 0001209191-20-005781 | 7244 |
One latest value per concept from companyfacts (348 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 4.21M | 2026-11-16 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463638 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 9.61M | 2025-06-30 | 2025 | FY | 10-K/A | 2026-04-30 | 0001193125-26-197838 | |
| ecd | NonPeoNeoAvgCompActuallyPaidAmt | NonPeoNeoAvgCompActuallyPaidAmt | USD | 131,938 | 2025-01-01 | 2025-12-31 | PRE 14A | 2026-11-13 | 0001193125-26-461060 | ||
| ecd | NonPeoNeoAvgTotalCompAmt | NonPeoNeoAvgTotalCompAmt | USD | 143,118 | 2025-01-01 | 2025-12-31 | PRE 14A | 2026-11-13 | 0001193125-26-461060 | ||
| ecd | TotalShareholderRtnAmt | TotalShareholderRtnAmt | USD | 3.27 | 2025-01-01 | 2025-12-31 | PRE 14A | 2026-11-13 | 0001193125-26-461060 | ||
| ffd | NetFeeAmt | NetFeeAmt | USD | 57,508.48 | 2026-11-10 | S-3 | 2026-11-13 | 0001193125-26-458953 | |||
| ffd | TtlFeeAmt | TtlFeeAmt | USD | 57,508.48 | 2026-11-10 | S-3 | 2026-11-13 | 0001193125-26-458953 | |||
| ffd | TtlOfferingAmt | TtlOfferingAmt | USD | 661.02M | 2026-11-10 | S-3 | 2026-11-13 | 0001193125-26-458953 | |||
| ffd | TtlOffsetAmt | TtlOffsetAmt | USD | 0 | 2026-11-10 | S-3 | 2026-11-13 | 0001193125-26-458953 | |||
| ffd | TtlPrevslyPdAmt | TtlPrevslyPdAmt | USD | 0 | 2026-11-10 | S-3 | 2026-11-13 | 0001193125-26-458953 | |||
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 796,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463638 | |
| us-gaap | AccruedBonusesCurrent | Accrued Bonuses, Current | USD | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-31 | 0000950170-25-047758 | |
| us-gaap | AccruedIncomeTaxesCurrent | Accrued Income Taxes, Current | USD | 54,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-134720 | |
| us-gaap | AccruedLiabilitiesCurrent | Accrued Liabilities, Current | USD | 151,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463638 | |
| us-gaap | AccruedPayrollTaxesCurrent | Accrued Payroll Taxes, Current | USD | 0 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-30 | 0000950170-22-004972 | |
| us-gaap | AccruedProfessionalFeesCurrent | Accrued Professional Fees, Current | USD | 23,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-134720 | |
| us-gaap | AccruedRentCurrent | Accrued Rent, Current | USD | 56,000 | 2016-12-31 | 2017 | FY | 10-K | 2018-03-01 | 0001193125-18-067077 | |
| us-gaap | AccruedVacationCurrent | Accrued Vacation, Current | USD | 227,000 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-30 | 0000950170-22-004972 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 7,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-134720 | |
| us-gaap | AdditionalPaidInCapitalCommonStock | Additional Paid in Capital, Common Stock | USD | 928.32M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463638 | |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 154,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463638 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs | USD | 2.70M | 2020-01-01 | 2020-03-31 | 2021 | Q1 | 10-Q | 2021-05-06 | 0001193125-21-153365 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalWarrantIssued | Adjustments to Additional Paid in Capital, Warrant Issued | USD | 1.02M | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-07 | 0000950170-23-006377 |
| us-gaap | AdministrativeFeesExpense | Administrative Fees Expense | USD | 250,000 | 2025-07-01 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-134720 | |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 3.51M | 2013-01-01 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-03 | 0001193125-14-080282 |
| us-gaap | AllocatedShareBasedCompensationExpenseNetOfTax | Share-based Payment Arrangement, Expense, after Tax | USD | 6.83M | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001193125-21-063387 |
| us-gaap | AllowanceForDoubtfulAccountsReceivableCurrent | Accounts Receivable, Allowance for Credit Loss, Current | USD | 322,000 | 2016-03-31 | 2016 | Q1 | 10-Q | 2016-05-10 | 0001193125-16-585559 | |
| us-gaap | AmortizationOfFinancingCosts | Amortization of Debt Issuance Costs | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-31 | 0000950170-25-047758 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 749,932 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463638 |
| us-gaap | AssetImpairmentCharges | Asset Impairment Charges | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-31 | 0000950170-25-047758 |
| us-gaap | Assets | Assets | USD | 1.92M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463638 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 1.08M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463638 | |
| us-gaap | BankingFeesAndCommissions | Banking Fees and Commissions (Deprecated 2018-01-31) | USD | 2.20M | 2010-05-01 | 2010-05-27 | 2013 | FY | 10-K | 2014-03-03 | 0001193125-14-080282 |
| us-gaap | CapitalExpendituresIncurredButNotYetPaid | Capital Expenditures Incurred but Not yet Paid | USD | 0 | 2024-01-01 | 2024-03-31 | 2024 | Q1 | 10-Q | 2024-05-15 | 0000950170-24-060075 |
| us-gaap | CapitalizedComputerSoftwareGross | Capitalized Computer Software, Gross | USD | 886,000 | 2015-12-31 | 2015 | FY | 10-K | 2016-02-24 | 0001193125-16-475875 | |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 615,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463638 | |
| us-gaap | CashAndCashEquivalentsFairValueDisclosure | Cash and Cash Equivalents, Fair Value Disclosure | USD | 66.79M | 2013-12-31 | 2013 | FY | 10-K | 2014-03-03 | 0001193125-14-080282 | |
| us-gaap | CashAndCashEquivalentsPeriodIncreaseDecrease | Cash and Cash Equivalents, Period Increase (Decrease) | USD | -10.11M | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-01 | 0001193125-18-067077 |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 615,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463638 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect | USD | -30.54M | 2018-01-01 | 2018-06-30 | 2018 | Q2 | 10-Q | 2018-08-08 | 0001193125-18-242705 |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | -770,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463638 |
| us-gaap | ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights | Class of Warrant or Right, Exercise Price of Warrants or Rights (Deprecated 2014-01-31) | USD/Right | 5.75 | 2007-02-23 | 2013 | Q3 | 10-Q | 2013-10-22 | 0001193125-13-406591 | |
| us-gaap | ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 | Class of Warrant or Right, Exercise Price of Warrants or Rights | USD/shares | 9.63 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463638 | |
| us-gaap | ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights | Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares | 18.94M | 2018-11-11 | 2020 | FY | 10-K | 2021-03-01 | 0001193125-21-063387 | |
| us-gaap | ClassOfWarrantOrRightOutstanding | Class of Warrant or Right, Outstanding | shares | 106,452 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463638 | |
| us-gaap | CommonStockCapitalSharesReservedForFutureIssuance | Common Stock, Capital Shares Reserved for Future Issuance | shares | 31.12M | 2021-02-24 | 2020 | FY | 10-K | 2021-03-01 | 0001193125-21-063387 | |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0.001 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463638 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 50.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463638 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 3.32M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463638 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 3.32M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463638 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 3,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463638 | |
| us-gaap | ContractRevenueCost | Contract Revenue Cost (Deprecated 2018-01-31) | USD | 116.25M | 2003-09-09 | 2011-09-30 | 2011 | Q3 | 10-Q | 2011-11-03 | 0001144204-11-061165 |
| us-gaap | ContractsRevenue | Contracts Revenue (Deprecated 2018-01-31) | USD | 146,000 | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-10 | 0001193125-18-159174 |
| us-gaap | ConversionOfStockAmountConverted1 | Conversion of Stock, Amount Converted | USD | 692,000 | 2014-01-01 | 2014-12-31 | 2016 | FY | 10-K | 2017-02-16 | 0001193125-17-046668 |
| us-gaap | CumulativeEffectOnRetainedEarningsNetOfTax1 | Cumulative Effect on Retained Earnings, Net of Tax (Deprecated 2020-01-31) | USD | -8.13M | 2018-01-01 | 2018-12-31 | 2019 | FY | 10-K | 2020-03-02 | 0001193125-20-058863 |
| us-gaap | DebtConversionConvertedInstrumentAmount1 | Debt Conversion, Converted Instrument, Amount | USD | 54,000 | 2014-01-01 | 2014-12-31 | 2016 | FY | 10-K | 2017-02-16 | 0001193125-17-046668 |
| us-gaap | DebtInstrumentBasisSpreadOnVariableRate1 | Debt Instrument, Basis Spread on Variable Rate | pure | 0.045 | 2021-08-06 | 2024 | FY | 10-K | 2025-03-31 | 0000950170-25-047758 | |
| us-gaap | DebtInstrumentCarryingAmount | Long-term Debt, Gross | USD | 16.77M | 2022-12-31 | 2023 | FY | 10-K | 2024-04-01 | 0000950170-24-038868 | |
| us-gaap | DeferredCompensationArrangementWithIndividualSharesIssued | Deferred Compensation Arrangement with Individual, Shares Issued | shares | 446,428 | 2019-01-01 | 2019-01-06 | 2020 | Q3 | 10-Q | 2020-11-05 | 0001193125-20-286807 |
| us-gaap | DeferredRentCredit | Deferred Rent Credit | USD | 17,000 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-05 | 0001193125-19-063978 | |
| us-gaap | DeferredRentCreditCurrent | Deferred Rent Credit, Current | USD | 13,000 | 2018-12-31 | 2019 | FY | 10-K | 2020-03-02 | 0001193125-20-058863 | |
| us-gaap | DeferredRentCreditNoncurrent | Deferred Rent Credit, Noncurrent | USD | 4,000 | 2018-12-31 | 2019 | FY | 10-K | 2020-03-02 | 0001193125-20-058863 | |
| us-gaap | DeferredRevenue | Deferred Revenue | USD | 41.50M | 2017-12-31 | 2019 | FY | 10-K | 2020-03-02 | 0001193125-20-058863 | |
| us-gaap | DeferredRevenueCurrent | Deferred Revenue, Current | USD | 6.39M | 2017-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001193125-21-063387 | |
| us-gaap | DeferredRevenueNoncurrent | Deferred Revenue, Noncurrent | USD | 35.14M | 2017-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001193125-21-063387 | |
| us-gaap | DeferredTaxAssetsDeferredIncome | Deferred Tax Assets, Deferred Income | USD | 0 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-05 | 0001193125-19-063978 | |
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 213.58M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-134720 | |
| us-gaap | DeferredTaxAssetsLiabilitiesNet | Deferred Tax Assets, Net | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-134720 | |
| us-gaap | DeferredTaxAssetsNet | Deferred Tax Assets, Net of Valuation Allowance | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-134720 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwards | Deferred Tax Assets, Operating Loss Carryforwards | USD | 163.25M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-134720 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration | Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration | USD | 436.00M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-134720 | |
| us-gaap | DeferredTaxAssetsOther | Deferred Tax Assets, Other | USD | -20,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-134720 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwardsResearch | Deferred Tax Assets, Tax Credit Carryforwards, Research | USD | 40.34M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-134720 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits | USD | 766,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-134720 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 213.58M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-134720 | |
| us-gaap | DeferredTaxLiabilities | Deferred Tax Liabilities, Net | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-134720 | |
| us-gaap | DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityBadDebtReserveForTaxPurposesOfQualifiedLender | Deferred Tax Liability Not Recognized, Amount of Unrecognized Deferred Tax Liability, Bad Debt Reserve for Tax Purposes of Qualified Lender | USD | 57,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463638 | |
| us-gaap | DefinedBenefitPlanContributionsByEmployer | Defined Benefit Plan, Plan Assets, Contributions by Employer | USD | 13,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-134720 |
| us-gaap | DepositsAssetsNoncurrent | Deposits Assets, Noncurrent | USD | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-04-01 | 0000950170-24-038868 | |
| us-gaap | Depreciation | Depreciation | USD | 25,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463638 |
| us-gaap | DepreciationAndAmortization | Depreciation, Depletion and Amortization, Nonproduction | USD | 412,000 | 2018-01-01 | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-09 | 0001193125-18-323155 |
| us-gaap | DerivativeFairValueOfDerivativeLiability | Derivative Liability, Fair Value, Gross Liability | USD | 0 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001193125-21-063387 | |
| us-gaap | DerivativeGainLossOnDerivativeNet | Derivative, Gain (Loss) on Derivative, Net | USD | 0 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001193125-21-063387 |
| us-gaap | DerivativeLiabilitiesNoncurrent | Derivative Liability, Noncurrent | USD | 2.42M | 2017-12-31 | 2018 | FY | 10-K | 2019-03-05 | 0001193125-19-063978 | |
| us-gaap | DerivativeLiabilityFairValueOfCollateral | Derivative Liability, Fair Value of Collateral | USD | 31,000 | 2025-06-09 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-134720 | |
| us-gaap | DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage | Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) | USD | 350.54M | 2014-03-31 | 2014 | Q1 | 10-Q | 2014-05-08 | 0001193125-14-189905 | |
| us-gaap | DilutiveSecurities | Dilutive Securities, Effect on Basic Earnings Per Share | USD | 201.49M | 2018-01-01 | 2018-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001193125-21-063387 |
| us-gaap | DividendsPreferredStock | Dividends, Preferred Stock | USD | 17.00M | 2018-01-01 | 2018-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001193125-21-063387 |
| us-gaap | DueToRelatedPartiesCurrentAndNoncurrent | Due to Related Parties | USD | 100,000 | 2019-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001193125-21-063387 | |
| us-gaap | DueToRelatedPartiesNoncurrent | Due to Related Parties, Noncurrent | USD | 119.05M | 2016-06-30 | 2016 | Q2 | 10-Q | 2016-08-09 | 0001193125-16-676724 | |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -1.04 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463638 |
| us-gaap | EarningsPerShareBasicAndDiluted | Earnings Per Share, Basic and Diluted | USD/shares | -0.05 | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-16 | 0000950170-22-009942 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -1.04 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463638 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-134720 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-134720 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | -0.07 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-134720 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-134720 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-134720 |
| us-gaap | EffectiveIncomeTaxRateReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent | pure | 0 | 2019-01-01 | 2019-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001193125-21-063387 |
| us-gaap | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | pure | -0.05 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-134720 |
| us-gaap | EmployeeBenefitsAndShareBasedCompensationNoncash | Employee Benefit and Share-based Payment Arrangement, Noncash | USD | 154,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463638 |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized | Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount | USD | 8.50M | 2013-12-31 | 2013 | FY | 10-K | 2014-03-03 | 0001193125-14-080282 | |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions | Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount | USD | 2,400 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-08 | 0000950170-21-003463 | |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount | USD | 5.10M | 2015-09-30 | 2015 | Q3 | 10-Q | 2015-11-02 | 0001193125-15-362281 | |
| us-gaap | EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense | Share-based Payment Arrangement, Expense, Tax Benefit | USD | 0 | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-05 | 0001193125-19-063978 |
| us-gaap | FairValueAdjustmentOfWarrants | Fair Value Adjustment of Warrants | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463638 |
| us-gaap | FairValueAssumptionsRiskFreeInterestRate | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) | pure | 0.05 | 2013-01-01 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-03 | 0001193125-14-080282 |
| us-gaap | FinanceLeaseLiabilityCurrent | Finance Lease, Liability, Current | USD | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-04-01 | 0000950170-24-038868 | |
| us-gaap | FinanceLeaseLiabilityNoncurrent | Finance Lease, Liability, Noncurrent | USD | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-04-01 | 0000950170-24-038868 | |
| us-gaap | GainLossOnDispositionOfAssets1 | Gain (Loss) on Disposition of Assets | USD | -600,000 | 2013-01-01 | 2013-12-31 | 2015 | FY | 10-K | 2016-02-24 | 0001193125-16-475875 |
| us-gaap | GainLossOnSaleOfBusiness | Gain (Loss) on Disposition of Business | USD | -800,000 | 2013-01-01 | 2013-12-31 | 2015 | FY | 10-K | 2016-02-24 | 0001193125-16-475875 |
| us-gaap | GainLossOnSaleOfPropertyPlantEquipment | Gain (Loss) on Disposition of Property Plant Equipment | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-31 | 0000950170-25-047758 |
| us-gaap | GainLossOnTerminationOfLease | Gain (Loss) on Termination of Lease | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-31 | 0000950170-25-047758 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 1.68M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463638 |
| us-gaap | IncomeTaxesPaid | Income Taxes Paid | USD | 0 | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-10 | 0001193125-18-159174 |
| us-gaap | IncomeTaxesPaidNet | Income Taxes Paid, Net | USD | 0 | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-05 | 0001193125-19-063978 |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-134720 |
| us-gaap | IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | USD | 305,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-134720 |
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | -859,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-134720 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Amount | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-134720 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount | USD | 18,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-134720 |
| us-gaap | IncomeTaxReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount | USD | 196,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-134720 |
| us-gaap | IncreaseDecreaseInAccountsPayable | Increase (Decrease) in Accounts Payable | USD | 183,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463638 |
| us-gaap | IncreaseDecreaseInAccruedLiabilities | Increase (Decrease) in Accrued Liabilities | USD | -49,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463638 |
| us-gaap | IncreaseDecreaseInContractWithCustomerLiability | Increase (Decrease) in Contract with Customer, Liability | USD | -146,000 | 2018-01-01 | 2018-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001193125-21-063387 |
| us-gaap | IncreaseDecreaseInDeferredLiabilities | Increase (Decrease) in Deferred Liabilities | USD | -125,000 | 2018-01-01 | 2018-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001193125-21-063387 |
| us-gaap | IncreaseDecreaseInDeferredRevenue | Increase (Decrease) in Deferred Revenue | USD | -146,000 | 2018-01-01 | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-09 | 0001193125-18-323155 |
| us-gaap | IncreaseDecreaseInDepositOtherAssets | Increase (Decrease) in Deposit Assets | USD | -4,000 | 2013-01-01 | 2013-12-31 | 2014 | FY | 10-K | 2015-02-26 | 0001193125-15-065956 |
| us-gaap | IncreaseDecreaseInDeposits | Increase (Decrease) in Deposits | USD | -2,000 | 2019-01-01 | 2019-06-30 | 2019 | Q2 | 10-Q | 2019-08-08 | 0001193125-19-216056 |
| us-gaap | IncreaseDecreaseInOtherDeferredLiability | Increase (Decrease) in Other Deferred Liability | USD | 19,000 | 2015-01-01 | 2015-06-30 | 2015 | Q2 | 10-Q | 2015-08-10 | 0001193125-15-284805 |
| us-gaap | IncreaseDecreaseInOtherNoncurrentAssets | Increase (Decrease) in Other Noncurrent Assets | USD | -500,000 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-04-01 | 0000950170-24-038868 |
| us-gaap | IncreaseDecreaseInOtherNoncurrentLiabilities | Increase (Decrease) in Other Noncurrent Liabilities | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-31 | 0000950170-25-047758 |
| us-gaap | IncreaseDecreaseInOtherOperatingLiabilities | Increase (Decrease) in Other Operating Liabilities | USD | 7,000 | 2019-01-01 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-07 | 0001193125-19-287259 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | -250,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463638 |
| us-gaap | IncreaseDecreaseInReceivables | Increase (Decrease) in Receivables | USD | -3,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463638 |
| us-gaap | IncrementalCommonSharesAttributableToShareBasedPaymentArrangements | Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements | shares | 201,362 | 2018-01-01 | 2018-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001193125-21-063387 |
| us-gaap | InterestExpense | Interest Expense | USD | 0 | 2024-01-01 | 2024-06-30 | 2024 | Q2 | 10-Q | 2024-08-14 | 0000950170-24-097142 |
| us-gaap | InterestExpenseDebt | Interest Expense, Debt | USD | 1.90M | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-03-31 | 0000950170-25-047758 |
| us-gaap | InterestExpenseNonoperating | InterestExpenseNonoperating | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-31 | 0000950170-25-047758 |
| us-gaap | InterestIncomeExpenseNet | Interest Income (Expense), Net | USD | -444,000 | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-08 | 0000950170-21-003463 |
| us-gaap | InterestPaid | Interest Paid, Including Capitalized Interest, Operating and Investing Activities | USD | 0 | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-10 | 0001193125-18-159174 |
| us-gaap | InterestPaidNet | Interest Paid, Excluding Capitalized Interest, Operating Activities | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-134720 |
| us-gaap | InvestmentBankingAdvisoryBrokerageAndUnderwritingFeesAndCommissions | Investment Banking, Advisory, Brokerage, and Underwriting Fees and Commissions | USD | 1.00M | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001193125-21-063387 |
| us-gaap | IssuanceOfStockAndWarrantsForServicesOrClaims | Issuance of Stock and Warrants for Services or Claims | USD | 67.28M | 2015-01-01 | 2015-12-31 | 2017 | FY | 10-K | 2018-03-01 | 0001193125-18-067077 |
| us-gaap | LandSubjectToGroundLeases | Land Subject to Ground Leases | sqft | 9,800 | 2021-04-22 | 2021 | Q3 | 10-Q | 2021-11-08 | 0000950170-21-003463 | |
| us-gaap | LeaseAndRentalExpense | Operating Leases, Rent Expense | USD | 5,000 | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-08 | 0000950170-21-003463 |
| us-gaap | LeaseCost | Lease, Cost | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-31 | 0000950170-25-047758 |
| us-gaap | LeaseholdImprovementsGross | Leasehold Improvements, Gross | USD | 990,000 | 2015-12-31 | 2015 | FY | 10-K | 2016-02-24 | 0001193125-16-475875 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDue | Lessee, Operating Lease, Liability, to be Paid | USD | 3.24M | 2022-12-31 | 2022 | FY | 10-K | 2023-03-07 | 0000950170-23-006377 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive | Lessee, Operating Lease, Liability, to be Paid, after Year Five | USD | 31,000 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-07 | 0000950170-23-006377 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour | Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Four | USD | 375,000 | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-05 | 0001193125-20-286807 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree | Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Three | USD | 364,000 | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-05 | 0001193125-20-286807 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo | Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Two | USD | 353,000 | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-05 | 0001193125-20-286807 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths | Lessee, Operating Lease, Liability, Payments, Due Next Rolling Twelve Months | USD | 896,000 | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-05 | 0001193125-20-286807 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths | Lessee, Operating Lease, Liability, to be Paid, Year One | USD | 757,000 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-07 | 0000950170-23-006377 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFive | Lessee, Operating Lease, Liability, to be Paid, Year Five | USD | 158,000 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-07 | 0000950170-23-006377 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFour | Lessee, Operating Lease, Liability, to be Paid, Year Four | USD | 712,000 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-07 | 0000950170-23-006377 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearThree | Lessee, Operating Lease, Liability, to be Paid, Year Three | USD | 804,000 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-07 | 0000950170-23-006377 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearTwo | Lessee, Operating Lease, Liability, to be Paid, Year Two | USD | 780,000 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-07 | 0000950170-23-006377 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear | Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year | USD | 273,000 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-08 | 0000950170-21-003463 | |
| us-gaap | LesseeOperatingLeaseLiabilityUndiscountedExcessAmount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | USD | 496,000 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-07 | 0000950170-23-006377 | |
| us-gaap | LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths | Lessor, Operating Lease, Payment to be Received, Year One | USD | 200,000 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-07 | 0000950170-23-006377 | |
| us-gaap | LessorOperatingLeasePaymentsToBeReceivedThreeYears | Lessor, Operating Lease, Payment to be Received, Year Three | USD | 100,000 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-07 | 0000950170-23-006377 | |
| us-gaap | LessorOperatingLeasePaymentsToBeReceivedTwoYears | Lessor, Operating Lease, Payment to be Received, Year Two | USD | 200,000 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-07 | 0000950170-23-006377 | |
| us-gaap | Liabilities | Liabilities | USD | 947,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463638 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 1.92M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463638 | |
| us-gaap | LiabilitiesAssumed1 | Liabilities Assumed | USD | 119.05M | 2016-01-01 | 2016-06-30 | 2016 | Q2 | 10-Q | 2016-08-09 | 0001193125-16-676724 |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 947,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463638 | |
| us-gaap | LitigationSettlementExpense | Litigation Settlement, Expense | USD | 1.00M | 2023-10-20 | 2024 | FY | 10-K | 2025-03-31 | 0000950170-25-047758 | |
| us-gaap | LongTermDebtCurrent | Long-term Debt, Current Maturities | USD | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-04-01 | 0000950170-24-038868 | |
| us-gaap | LongTermDebtNoncurrent | Long-term Debt, Excluding Current Maturities | USD | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-31 | 0000950170-25-047758 | |
| us-gaap | LongTermPurchaseCommitmentAmount | Long-term Purchase Commitment, Amount | USD | 50.00M | 2013-01-01 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-03 | 0001193125-14-080282 |
| us-gaap | LossContingencyAccrualCarryingValueCurrent | Loss Contingency, Accrual, Current | USD | 1.00M | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-14 | 0000950170-23-063354 | |
| us-gaap | LossContingencyDamagesSoughtValue | Loss Contingency, Damages Sought, Value | USD | 3.20M | 2023-03-17 | 2024 | FY | 10-K | 2025-03-31 | 0000950170-25-047758 | |
| us-gaap | MachineryAndEquipmentGross | Machinery and Equipment, Gross | USD | 572,000 | 2015-12-31 | 2015 | FY | 10-K | 2016-02-24 | 0001193125-16-475875 | |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 986,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463638 |
| us-gaap | NetCashProvidedByUsedInFinancingActivitiesContinuingOperations | Net Cash Provided by (Used in) Financing Activities, Continuing Operations | USD | -731,000 | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-10 | 0001193125-18-159174 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463638 |
| us-gaap | NetCashProvidedByUsedInInvestingActivitiesContinuingOperations | Net Cash Provided by (Used in) Investing Activities, Continuing Operations | USD | -150,000 | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-10 | 0001193125-18-159174 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -1.76M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463638 |
| us-gaap | NetCashProvidedByUsedInOperatingActivitiesContinuingOperations | Net Cash Provided by (Used in) Operating Activities, Continuing Operations | USD | -18.96M | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-10 | 0001193125-18-159174 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -2.73M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463638 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersBasic | Net Income (Loss) Available to Common Stockholders, Basic | USD | -2.84M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463638 |
| us-gaap | NewAccountingPronouncementOrChangeInAccountingPrincipleCumulativeEffectOfChangeOnEquityOrNetAssets | New Accounting Pronouncement or Change in Accounting Principle, Cumulative Effect of Change on Equity or Net Assets (Deprecated 2012-01-31) | USD | -72,000 | 2009-01-01 | 2009-12-31 | 2011 | FY | 10-K | 2012-02-29 | 0001144204-12-012003 |
| us-gaap | NewAccountingPronouncementOrChangeInAccountingPrincipleCumulativeEffectOfChangeOnEquityOrNetAssets1 | New Accounting Pronouncement or Change in Accounting Principle, Cumulative Effect of Change on Equity or Net Assets (Deprecated 2020-01-31) | USD | -122,000 | 2017-03-31 | 2017 | Q1 | 10-Q | 2017-05-01 | 0001193125-17-151749 | |
| us-gaap | NoninterestExpenseTransferAgentAndCustodianFees | Noninterest Expense Transfer Agent and Custodian Fees | USD | 455,000 | 2009-08-16 | 2009-09-15 | 2013 | FY | 10-K | 2014-03-03 | 0001193125-14-080282 |
| us-gaap | NonoperatingIncomeExpense | Nonoperating Income (Expense) | USD | -6,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463638 |
| us-gaap | OperatingCostsAndExpenses | Operating Costs and Expenses | USD | 22.77M | 2020-10-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001193125-21-063387 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 2.72M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463638 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -2.72M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463638 |
| us-gaap | OperatingLeaseCost | Operating Lease, Cost | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-31 | 0000950170-25-047758 |
| us-gaap | OperatingLeaseImpairmentLoss | Operating Lease, Impairment Loss | USD | 600,000 | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-07 | 0000950170-23-006377 |
| us-gaap | OperatingLeaseLiability | Operating Lease, Liability | USD | 2.75M | 2022-12-31 | 2022 | FY | 10-K | 2023-03-07 | 0000950170-23-006377 | |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 0 | 2023-12-31 | 2024 | FY | 10-K | 2025-03-31 | 0000950170-25-047758 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 4.71M | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-08 | 0000950170-21-003463 | |
| us-gaap | OperatingLeasePayments | Operating Lease, Payments | USD | 400,000 | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-03-31 | 0000950170-25-047758 |
| us-gaap | OperatingLeaseResidualValueOfLeasedAsset | Operating Lease, Residual Value of Leased Asset | USD | 1.40M | 2021-12-31 | 2022 | FY | 10-K | 2023-03-07 | 0000950170-23-006377 | |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-04-01 | 0000950170-24-038868 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDue | Operating Leases, Future Minimum Payments Due | USD | 1.95M | 2018-12-31 | 2019 | FY | 10-K | 2020-03-02 | 0001193125-20-058863 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueCurrent | Operating Leases, Future Minimum Payments Due, Next Twelve Months | USD | 723,000 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-05 | 0001193125-19-063978 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals | Operating Leases, Future Minimum Payments Due, Future Minimum Sublease Rentals | USD | 278,000 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-01 | 0001193125-18-067077 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInFiveYears | Operating Leases, Future Minimum Payments, Due in Five Years | USD | 0 | 2014-12-31 | 2014 | FY | 10-K | 2015-02-26 | 0001193125-15-065956 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInFourYears | Operating Leases, Future Minimum Payments, Due in Four Years | USD | 489,000 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-01 | 0001193125-18-067077 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInThreeYears | Operating Leases, Future Minimum Payments, Due in Three Years | USD | 488,000 | 2018-12-31 | 2019 | FY | 10-K | 2020-03-02 | 0001193125-20-058863 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInTwoYears | Operating Leases, Future Minimum Payments, Due in Two Years | USD | 736,000 | 2018-12-31 | 2019 | FY | 10-K | 2020-03-02 | 0001193125-20-058863 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueThereafter | Operating Leases, Future Minimum Payments, Due Thereafter | USD | 424,000 | 2012-12-31 | 2012 | FY | 10-K | 2013-03-18 | 0001193125-13-112464 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear | Operating Leases, Future Minimum Payments, Remainder of Fiscal Year | USD | 723,000 | 2018-12-31 | 2019 | FY | 10-K | 2020-03-02 | 0001193125-20-058863 | |
| us-gaap | OperatingLeasesRentExpenseNet | Operating Leases, Rent Expense, Net | USD | 700,000 | 2018-01-01 | 2018-12-31 | 2019 | FY | 10-K | 2020-03-02 | 0001193125-20-058863 |
| us-gaap | OperatingLeaseWeightedAverageDiscountRatePercent | Operating Lease, Weighted Average Discount Rate, Percent | pure | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-31 | 0000950170-25-047758 | |
| us-gaap | OtherAccruedLiabilitiesCurrent | Other Accrued Liabilities, Current | USD | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-04-01 | 0000950170-24-038868 | |
| us-gaap | OtherAccruedLiabilitiesCurrentAndNoncurrent | Other Accrued Liabilities | USD | 500,000 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-30 | 0000950170-22-004972 | |
| us-gaap | OtherAdditionalCapital | Other Additional Capital | USD | 3.60M | 2013-12-31 | 2014 | FY | 10-K | 2015-02-26 | 0001193125-15-065956 | |
| us-gaap | OtherAssetImpairmentCharges | Other Asset Impairment Charges | USD | 100,000 | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-07 | 0000950170-23-006377 |
| us-gaap | OtherAssetsNoncurrent | Other Assets, Noncurrent | USD | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-04-01 | 0000950170-24-038868 | |
| us-gaap | OtherEmployeeRelatedLiabilitiesCurrent | Other Employee-related Liabilities, Current | USD | 474,000 | 2012-12-31 | 2013 | FY | 10-K | 2014-03-03 | 0001193125-14-080282 | |
| us-gaap | OtherLiabilitiesNoncurrent | Other Liabilities, Noncurrent | USD | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-04-01 | 0000950170-24-038868 | |
| us-gaap | OtherNoncashIncomeExpense | Other Noncash Income (Expense) | USD | 11.96M | 2003-09-10 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-03 | 0001193125-14-080282 |
| us-gaap | OtherNonoperatingGainsLosses | Other Nonoperating Gains (Losses) | USD | 13.75M | 2003-09-10 | 2013-09-30 | 2013 | Q3 | 10-Q | 2013-10-22 | 0001193125-13-406591 |
| us-gaap | OtherNonoperatingIncomeExpense | Other Nonoperating Income (Expense) | USD | -6,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463638 |
| us-gaap | PaymentsForCommissions | Payments for Commissions | USD | 1.70M | 2013-01-01 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-03 | 0001193125-14-080282 |
| us-gaap | PaymentsForRepurchaseOfCommonStock | Payments for Repurchase of Common Stock | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-04-01 | 0000950170-24-038868 |
| us-gaap | PaymentsForRepurchaseOfEquity | Payments for Repurchase of Equity | USD | 1.27M | 2018-01-01 | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-09 | 0001193125-18-323155 |
| us-gaap | PaymentsForRepurchaseOfOtherEquity | Payments for Repurchase of Other Equity | USD | 246,000 | 2015-01-01 | 2015-06-30 | 2015 | Q2 | 10-Q | 2015-08-10 | 0001193125-15-284805 |
| us-gaap | PaymentsForUnderwritingExpense | Payments for Underwriting Expense | USD | 2.80M | 2009-11-01 | 2009-12-04 | 2013 | FY | 10-K | 2014-03-03 | 0001193125-14-080282 |
| us-gaap | PaymentsOfDebtExtinguishmentCosts | Payment for Debt Extinguishment or Debt Prepayment Cost | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-31 | 0000950170-25-047758 |
| us-gaap | PaymentsOfDebtIssuanceCosts | Payments of Debt Issuance Costs | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-07 | 0000950170-23-006377 |
| us-gaap | PaymentsOfDistributionsToAffiliates | Payments of Distributions to Affiliates | USD | 425,000 | 2005-08-14 | 2005-09-13 | 2013 | FY | 10-K | 2014-03-03 | 0001193125-14-080282 |
| us-gaap | PaymentsToAcquireInterestInJointVenture | Payments to Acquire Interest in Joint Venture | USD | 35.00M | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-05 | 0001193125-19-063978 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463638 |
| us-gaap | PostemploymentBenefitsPeriodExpense | Postemployment Benefits, Period Expense | USD | 3.50M | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-08 | 0000950170-21-003463 |
| us-gaap | PreferredStockDividendsAndOtherAdjustments | Preferred Stock Dividends and Other Adjustments | USD | 109,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463638 |
| us-gaap | PreferredStockDividendsIncomeStatementImpact | Preferred Stock Dividends, Income Statement Impact | USD | 17.00M | 2018-01-01 | 2018-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001193125-21-063387 |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0.001 | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-05-06 | 0001193125-21-153365 | |
| us-gaap | PreferredStockRedemptionDiscount | Preferred Stock Redemption Discount | USD | 207.36M | 2018-01-01 | 2018-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001193125-21-063387 |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 30.00M | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-05-06 | 0001193125-21-153365 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 0 | 2016-09-30 | 2016 | Q3 | 10-Q | 2016-11-09 | 0001193125-16-764305 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 0 | 2016-09-30 | 2016 | Q3 | 10-Q | 2016-11-09 | 0001193125-16-764305 | |
| us-gaap | PreferredStockValue | Preferred Stock, Value, Issued | USD | 0 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-03 | 0001193125-14-080282 | |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 461,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463638 | |
| us-gaap | PrepaidExpenseAndOtherAssetsNoncurrent | Prepaid Expense and Other Assets, Noncurrent | USD | 776,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463638 | |
| us-gaap | ProceedsFromContributedCapital | Proceeds from Contributed Capital | USD | 500,000 | 2003-09-10 | 2014-03-31 | 2014 | Q1 | 10-Q | 2014-05-08 | 0001193125-14-189905 |
| us-gaap | ProceedsFromIssuanceInitialPublicOffering | Proceeds from Issuance Initial Public Offering | USD | 6.08M | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-02 | 0001193125-20-058863 |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-31 | 0000950170-25-047758 |
| us-gaap | ProceedsFromIssuanceOfLongTermDebt | Proceeds from Issuance of Long-term Debt | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-07 | 0000950170-23-006377 |
| us-gaap | ProceedsFromIssuanceOfPreferredStockAndPreferenceStock | Proceeds from Issuance of Preferred Stock and Preference Stock | USD | 16.76M | 2003-09-10 | 2014-03-31 | 2014 | Q1 | 10-Q | 2014-05-08 | 0001193125-14-189905 |
| us-gaap | ProceedsFromIssuanceOfPrivatePlacement | Proceeds from Issuance of Private Placement | USD | 52.50M | 2019-09-12 | 2024 | Q1 | 10-Q | 2024-05-15 | 0000950170-24-060075 | |
| us-gaap | ProceedsFromIssuanceOfWarrants | Proceeds from Issuance of Warrants | USD | 788,000 | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-08 | 0000950170-21-003463 |
| us-gaap | ProceedsFromRepaymentsOfLinesOfCredit | Proceeds from (Repayments of) Lines of Credit | USD | 70,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463638 |
| us-gaap | ProceedsFromRepaymentsOfRelatedPartyDebt | Proceeds from (Repayments of) Related Party Debt | USD | -5.41M | 2018-01-01 | 2018-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001193125-21-063387 |
| us-gaap | ProceedsFromSaleOfPropertyPlantAndEquipment | Proceeds from Sale of Property, Plant, and Equipment | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-31 | 0000950170-25-047758 |
| us-gaap | ProceedsFromStockOptionsExercised | Proceeds from Stock Options Exercised | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-04-01 | 0000950170-24-038868 |
| us-gaap | ProceedsFromWarrantExercises | Proceeds from Warrant Exercises | USD | 52.50M | 2019-01-01 | 2019-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001193125-21-063387 |
| us-gaap | ProfitLoss | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | USD | -40.64M | 2018-01-01 | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-09 | 0001193125-18-323155 |
| us-gaap | PropertyPlantAndEquipmentGross | Property, Plant and Equipment, Gross | USD | 98,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-134720 | |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 66,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463638 | |
| us-gaap | PurchaseCommitmentRemainingMinimumAmountCommitted | Purchase Commitment, Remaining Minimum Amount Committed | USD | 19.00M | 2013-12-31 | 2013 | FY | 10-K | 2014-03-03 | 0001193125-14-080282 | |
| us-gaap | ReceivablesNetCurrent | Receivables, Net, Current | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463638 | |
| us-gaap | RelatedPartyTransactionAmountsOfTransaction | Related Party Transaction, Amounts of Transaction | USD | 207.36M | 2018-10-01 | 2018-12-31 | 2019 | FY | 10-K | 2020-03-02 | 0001193125-20-058863 |
| us-gaap | RepaymentsOfLongTermDebt | Repayments of Long-term Debt | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-31 | 0000950170-25-047758 |
| us-gaap | RepaymentsOfRelatedPartyDebt | Repayments of Related Party Debt | USD | 180,000 | 2006-11-19 | 2006-12-18 | 2013 | FY | 10-K | 2014-03-03 | 0001193125-14-080282 |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 1.04M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463638 |
| us-gaap | RestrictedCash | Restricted Cash | USD | 13.90M | 2023-03-31 | 2023 | Q1 | 10-Q | 2023-05-10 | 0000950170-23-020088 | |
| us-gaap | RestrictedCashAndCashEquivalentsNoncurrent | Restricted Cash and Cash Equivalents, Noncurrent | USD | 691,000 | 2012-12-31 | 2012 | FY | 10-K | 2013-03-18 | 0001193125-13-112464 | |
| us-gaap | RestrictedCashCurrent | Restricted Cash, Current | USD | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-04-01 | 0000950170-24-038868 | |
| us-gaap | RestrictedCashNoncurrent | Restricted Cash, Noncurrent | USD | 388,000 | 2016-12-31 | 2018 | FY | 10-K | 2019-03-05 | 0001193125-19-063978 | |
| us-gaap | RestructuringAndRelatedCostNumberOfPositionsEliminatedInceptionToDate | Restructuring and Related Cost, Number of Positions Eliminated, Inception to Date | Position | 65 | 2013-04-03 | 2014 | Q3 | 10-Q | 2014-10-30 | 0001193125-14-389572 | |
| us-gaap | RestructuringCharges | Restructuring Charges | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-31 | 0000950170-25-047758 |
| us-gaap | RestructuringCosts | Restructuring Costs | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-31 | 0000950170-25-047758 |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -927.35M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463638 | |
| us-gaap | RevenueFromContractWithCustomerExcludingAssessedTax | Revenue from Contract with Customer, Excluding Assessed Tax | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463638 |
| us-gaap | RevenueFromContractWithCustomerIncludingAssessedTax | Revenue from Contract with Customer, Including Assessed Tax | USD | 398,000 | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-08 | 0000950170-21-003463 |
| us-gaap | RevenueRemainingPerformanceObligation | Revenue, Remaining Performance Obligation, Amount | USD | 57.50M | 2020-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001193125-21-063387 | |
| us-gaap | Revenues | Revenues | USD | 15.90M | 2017-01-01 | 2017-12-31 | 2019 | FY | 10-K | 2020-03-02 | 0001193125-20-058863 |
| us-gaap | RoyaltyExpense | Royalty Expense | USD | 0 | 2024-01-01 | 2024-06-30 | 2024 | Q2 | 10-Q | 2024-08-14 | 0000950170-24-097142 |
| us-gaap | SaleOfStockConsiderationReceivedOnTransaction | Sale of Stock, Consideration Received on Transaction | USD | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-30 | 0000950170-22-004972 |
| us-gaap | SaleOfStockPricePerShare | Sale of Stock, Price Per Share | USD/shares | 4.893 | 2017-05-11 | 2019 | FY | 10-K | 2020-03-02 | 0001193125-20-058863 | |
| us-gaap | SecurityDeposit | Security Deposit | USD | 2,000 | 2019-06-30 | 2019 | Q2 | 10-Q | 2019-08-08 | 0001193125-19-216056 | |
| us-gaap | SeveranceCosts1 | Severance Costs | USD | 1.30M | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-03-31 | 0000950170-25-047758 |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 562,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463638 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period | shares | 163,747 | 2013-01-01 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-03 | 0001193125-14-080282 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value | USD/shares | 4.42 | 2013-01-01 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-03 | 0001193125-14-080282 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period | shares | 805,900 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001193125-21-063387 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 4.34 | 2013-01-01 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-03 | 0001193125-14-080282 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number | shares | 352,865 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-03 | 0001193125-14-080282 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value | USD/shares | 4.38 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-03 | 0001193125-14-080282 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period | shares | 292,399 | 2013-01-01 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-03 | 0001193125-14-080282 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value | USD/shares | 4.31 | 2013-01-01 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-03 | 0001193125-14-080282 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | pure | 0 | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463638 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | pure | 1.251 | 2025-04-01 | 2025-06-30 | 2026 | Q2 | 10-Q | 2026-08-14 | 0001193125-26-352421 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum | pure | 1.27 | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463638 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum | pure | 1.193 | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463638 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | pure | 0.042 | 2025-04-01 | 2025-06-30 | 2026 | Q2 | 10-Q | 2026-08-14 | 0001193125-26-352421 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum | pure | 0.042 | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463638 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum | pure | 0.041 | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463638 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized | Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized | shares | 45,823 | 2012-01-01 | 2012-12-31 | 2012 | FY | 10-K | 2013-03-18 | 0001193125-13-112464 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant | Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant | shares | 484,156 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463638 | |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463638 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number | shares | 133,233 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463638 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | USD/shares | 32.66 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463638 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value | USD | 26,000 | 2022-01-01 | 2022-12-31 | 2023 | FY | 10-K | 2024-04-01 | 0000950170-24-038868 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period | shares | 3,085 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463638 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures | shares | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463638 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares | 506,000 | 2018-01-01 | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-09 | 0001193125-18-323155 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 2.16 | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 10-Q | 2025-08-14 | 0000950170-25-108887 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463638 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | shares | 219,400 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463638 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | USD/shares | 21.38 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463638 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value | USD | 3.32M | 2016-12-31 | 2016 | FY | 10-K | 2017-02-16 | 0001193125-17-046668 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number | shares | 6.71M | 2013-12-31 | 2013 | FY | 10-K | 2014-03-03 | 0001193125-14-080282 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price | USD/shares | 4.4 | 2016-12-31 | 2016 | FY | 10-K | 2017-02-16 | 0001193125-17-046668 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number | shares | 3.44M | 2016-12-31 | 2016 | FY | 10-K | 2017-02-16 | 0001193125-17-046668 | |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares | shares | 10,417 | 2021-04-29 | 2021 | Q3 | 10-Q | 2021-11-08 | 0000950170-21-003463 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost | Share-based Payment Arrangement, Plan Modification, Incremental Cost | USD | 201,000 | 2015-01-01 | 2015-09-30 | 2015 | Q3 | 10-Q | 2015-11-02 | 0001193125-15-362281 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | USD/shares | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463638 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price | USD/shares | 168.52 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463638 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | USD/shares | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463638 |
| us-gaap | SharePrice | Share Price | USD/shares | 3.5 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-03 | 0001193125-14-080282 | |
| us-gaap | ShortTermLeaseCost | Short-term Lease, Cost | USD | 0 | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-03-31 | 0000950170-25-047758 |
| us-gaap | SignificantPurchaseCommitmentRemainingMinimumAmountCommitted | Purchase Commitment, Remaining Minimum Amount Committed (Deprecated 2013-01-31) | USD | 29.00M | 2012-12-31 | 2012 | FY | 10-K | 2013-03-18 | 0001193125-13-112464 | |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 971,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463638 | |
| us-gaap | StockIssued1 | Stock Issued | USD | 67.28M | 2015-01-01 | 2015-12-31 | 2017 | FY | 10-K | 2018-03-01 | 0001193125-18-067077 |
| us-gaap | StockIssuedDuringPeriodSharesNewIssues | Stock Issued During Period, Shares, New Issues | shares | 2.81M | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001193125-21-063387 |
| us-gaap | StockIssuedDuringPeriodSharesStockOptionsExercised | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463638 |
| us-gaap | StockIssuedDuringPeriodValueIssuedForServices | Stock Issued During Period, Value, Issued for Services | USD | 408,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463638 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 916,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463638 |
| us-gaap | StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures | Stock Issued During Period, Value, Restricted Stock Award, Forfeitures | USD | 0 | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-08 | 0000950170-21-003463 |
| us-gaap | StockIssuedDuringPeriodValueRestrictedStockAwardGross | Stock Issued During Period, Value, Restricted Stock Award, Gross | USD | 1,000 | 2021-01-01 | 2021-06-30 | 2022 | Q2 | 10-Q | 2022-08-15 | 0000950170-22-017225 |
| us-gaap | StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures | Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures | USD | 0 | 2020-01-01 | 2020-06-30 | 2021 | Q2 | 10-Q | 2021-08-13 | 0000950170-21-001446 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 21,000 | 2022-01-01 | 2022-12-31 | 2023 | FY | 10-K | 2024-04-01 | 0000950170-24-038868 |
| us-gaap | StockRedeemedOrCalledDuringPeriodValue | Stock Redeemed or Called During Period, Value | USD | -370,000 | 2019-01-01 | 2019-09-30 | 2020 | Q3 | 10-Q | 2020-11-05 | 0001193125-20-286807 |
| us-gaap | StockRepurchasedAndRetiredDuringPeriodValue | Stock Repurchased and Retired During Period, Value | USD | 207.36M | 2018-01-01 | 2018-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001193125-21-063387 |
| us-gaap | StockRepurchasedDuringPeriodValue | Stock Repurchased During Period, Value | USD | 45,000 | 2022-01-01 | 2022-12-31 | 2023 | FY | 10-K | 2024-04-01 | 0000950170-24-038868 |
| us-gaap | TangibleAssetImpairmentCharges | Tangible Asset Impairment Charges | USD | 4.80M | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-03-31 | 0000950170-25-047758 |
| us-gaap | TaxCreditCarryforwardAmount | Tax Credit Carryforward, Amount | USD | 0 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-134720 | |
| us-gaap | UnrealizedGainLossOnDerivatives | Unrealized Gain (Loss) on Derivatives | USD | -3.53M | 2016-10-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-02-16 | 0001193125-17-046668 |
| us-gaap | UnrecognizedTaxBenefits | Unrecognized Tax Benefits | USD | 238,000 | 2014-12-31 | 2017 | FY | 10-K | 2018-03-01 | 0001193125-18-067077 | |
| us-gaap | UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities | Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities | USD | 0 | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-01 | 0001193125-18-067077 |
| us-gaap | UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-134720 |
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions | USD | 0 | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-01 | 0001193125-18-067077 |
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions | Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions | USD | -37,000 | 2013-01-01 | 2013-12-31 | 2014 | FY | 10-K | 2015-02-26 | 0001193125-15-065956 |
| us-gaap | UnrecognizedTaxBenefitsPeriodIncreaseDecrease | Unrecognized Tax Benefits, Period Increase (Decrease) | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-04-01 | 0000950170-24-038868 |
| us-gaap | UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations | Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations | USD | 0 | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-01 | 0001193125-18-067077 |
| us-gaap | ValuationAllowanceDeferredTaxAssetChangeInAmount | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | USD | 303,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-134720 |
| us-gaap | WarrantsAndRightsOutstanding | Warrants and Rights Outstanding | USD | 18.87M | 2008-12-31 | 2013 | FY | 10-K | 2014-03-03 | 0001193125-14-080282 | |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 2.72M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463638 |
| us-gaap | WeightedAverageNumberOfShareOutstandingBasicAndDiluted | Weighted Average Number of Shares Outstanding, Basic and Diluted | shares | 214.95M | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-16 | 0000950170-22-009942 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 2.72M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463638 |
| us-gaap | WorkersCompensationLiabilityCurrent | Workers' Compensation Liability, Current | USD | 3.30M | 2020-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001193125-21-063387 |